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OVERVIEW
ACTINOBACILLUS ACTINOMYCETEMCOMITANS
INDUCES EXPRESSION OF INTERLEUKIN-8 IN HUMAN
GINGIVAL EPITHELIAL CELLS: IMPLICATIONS FOR
THE PATHOGENESIS OF PERIODONTAL DISEASE
ABSTRACT
Introduction: The chemokine Interleukin 8 (IL-8) has been implicated in
inflammation and wound healing, but its role(s) and source(s) in periodontal disease are
not clearly understood. We hypothesized that: 1) in vivo, periodontopathic organisms
such as A. actinomycetemcomitans (A.a.) induce IL-8 expression in gingival epithelial
cells (GEC) and 2) this local expression of GEC-derived IL-8 enhances leukocyte,
vascular endothelial cell (VEC) and GEC migration via specific IL-8 receptors (IL-8R).
Objectives: To: 1) characterize the in vivo IL-8 and IL-8R expression in gingiva;
2) demonstrate the ability of A.a.-derived factors (A.a.DF) to induce IL-8 expression in
GEC in vitro; and 3) characterize the mechanisms by which A.a.DF induce IL-8
expression in GEC in vitro.
Methods: For in vivo studies, gingival specimens from patients with periodontitis
were evaluated for IL-8 and IL-8R expression using immunohistochemical (IHC)
techniques. For in vitro studies, we utilized the established GEC line PP. Cells were
cultured under various conditions and the IL-8 expression in the cell lysates and
supernatants was determined by ELISA.
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Results: In vivo, IL-8 and IL-8R expression was seen, in varying degrees, on
GECs, leukocytes and VECs. In vitro, A.a. extracts induced a time- and dose- dependent
expression of IL-8 from PP cells (7-fold, p<O.Ol). A.a. also induced expression of IL-la
and IL-l~, known IL-8 inducers. IL-8 expression was not inhibited by the LPS inhibitor
polymyxin B (p>O.lO) or anti-IL-lantibodies (p>O.lO). Interestingly the MAP kinase
inhibitor SB203580 markedly inhibited (>75%, p<O.Ol) A.a.-induced expression of IL-8.
In parallel studies, we have also demonstrated that A.a. can induce IL-6 expression from
PP cells.
Conclusions: GECs are a major source of IL-8 in vivo and in vitro. A.a.-derived
factors can induce IL-8 expression from GECs, in vitro. Althought A.a.-induced IL-8
expression involves a MAP kinase signal transducing pathway, it is not the direct result
of known IL-8 inducers (Le. LPS or IL-l). Our observation that A.a. can also induce IL-l
and IL-6 expression suggests that GEC may be a source of a variety of proinflammatory
cytokines, and therefore a potential target for therapeutic intervention in the future.
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INTRODUCTION
The most common cause of periodontal diseases is bacterial infection.
Actinobacillus actinomycetemcomitans (A.a.) is an important periodontal pathogen that
has been implicated in the pathogenesis of periodontitis. Prior studies have demonstrated
that this organism is found in periodontal pockets in patients with Localized Juvenile
Periodontitis (LJP) and has also been shown to invade human epithelial cells. Gingival
epithelium is the first tissue that encounters the bacterial invasion and is considered part
of the host's innate immunity.
Currently little is known about the role of the gingival epithelium in response the
specific infection with A.a. In fact, few studies have systematically examined the
epithelial chemokine responses, that are essential for the recruitment of leukocytes in the
periodontal pocket and the initiation of an inflammatory response.
In gingival biopsies, we were able to demonstrate the existence of Interleukin-8
(IL-8) and IL-8 receptors CXCR-l and CXCR-2. Based on these observations it is
hypothesized that bacterial infection induces significant upregulation of Interleukin-8
expression in the gingival epithelium, that may have chemotactic, angiogenic and
proliferative effects. To test this hypothesis, cultures of human gingival epithelial cells
will be infected with sonicated extracts of A. a. A systematic investigation of the
characteristics of the expression of IL-8 will be undertaken, in both unstimulated (resting)
and stimulated (infected) cells. Additionally, the role of Interleukin-l in the regulation of
Interleukin-8 will also be investigated. TIle results from these studies will not only
provide important information about the pathogenesis of microbial periodontal diseases,
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but will also provide the foundation for future therapeutic approaches based on
modification of cytokine responses of the host.
OVERALL HYPOTHESIS
During periodontal disease, periodontal pathogens such as A.a. induce expression
of proinflammatory cytokines in GEes. This local expression of GEC-derived cytokines,
controls inflammation and repair within the gingival tissue.
THESIS HYPOTHESIS
IL-8 and IL-8 receptors (IL-8R) are expressed by gingival epithelial cells (GECs)
in vivo and in vitro and A.a. extracts can induce IL-8 expression in GECs in vitro
SPECIFIC AIMS/OBJECTIVES
Our objective was to :
1) characterize the IL-8 and IL-8R expression in gingiva;
2) characterize the IL-8 and IL-8R expression in GEC, in vitro;
3) demonstrate the ability of A.a.-derived factors (A.a.DF) to induce IL-8 expression in
GEC in vitro; and
4) characterize the mechanisms by which A.a.DF induce IL-8 expression in GEC in vitro.
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BACKGROUND
Bacteria - Host interactions
Gingival tissues and especially the sulcular epithelium, encounters a wide
spectrum of oral microorganisms, that form the bacterial plaque, which is the main
causative factor of periodontal disease. Depending on the severity, the disease can be
classified into gingivitis, characterized by superficial inflammation and periodontitis,
characterized by attachment loss, alveolar bone loss and eventually tooth loss.
Recent microbiological studies of periodontal disease in humans have supported
the concept of a specific bacterial etiology. Among more than 300 species identified in
the oral cavity, a relatively small group of gram-negative organisms, are most frequently
isolated from infected periodontal pockets and are thus recognized as potential
periodontal pathogens. These include A.a., Bacteroides gingivalis, Eikenella corrodens
and Wolinella recta [1]. Etiologic role for Bacteroides forsythus, Treponema denticola
and Prevotella intermedia has also been suggested [2].
A.a. is probably one of the few microorganisms, that have been directly related to
periodontal lesions. Currently there is very little known about the interaction of this
bacterium with the gingival epithelium, except the fact that A.a. is capable of invading
oral epithelial cells, in vitro [3]. In addition, the cytokine functions of gingival epithelium
in response to bacterial infection have not been explored yet. The focus of our studies is
to provide further information about the role of the gingival keratinocyte in the early
chemokine signaling that will attract leukocytes in the gingival sulcus, as part of the host
defense. In order to describe a model for cellular interactions, we will study the
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expression of Interleukin-8 as a representative chemokine of the CXC family, having in
mind that similar conditions may apply for the other members of this family, too.
Actinobacillus actinomycetemcomitans
Actinobacillus actinomycetemcomitans (A.a.) is a small gram-negative
coccobacillus that has been implicated in the pathogenesis of adult periodontitis [4-6] and
localized juvenile periodontitis (LJP) [7]. A.a. has been shown to adhere to and invade
oral epithelial cells and some strains of A.a. express a toxin that enables them to kill
leukocytes [3] [8]. Several authors have investigated the inflammatory mediators and
cytokines produced by mononuclear cells and fibroblasts in response to A.a. challenge [9-
12]. However, little is known regarding the cytokine profile of GECs following their
interaction with this pathogen. As stated above, we hypotllesized that GECs behave as an
integral component of the immune system by increasing their constitutive expression of
IL-8 in response to A.a. infection.
CXC Chemokines
The a-subfamily of chemokines is characterized by a conserved tri-peptide near
the N-terminus, containing cysteines (C-X-C). CXC chemokines function as
chemoattractants and activators of leukocytes. They are involved in many physiological
processes, such as migration and release of leukocytes, inflammation, angiogenesis,
tumor growth and HIV-suppression [13, 14]. Until now, about 15 human CXC
chemokines have been discovered, including interleukin-8 (IL-8), GRO proteins (GRO-
alpha, GRO-beta and GRO-gamma), neutrophil-activating peptide-2 (NAP-2), platelet
factor 4(PF4) and gamma-interferon-inducible protein (IP10) [13].
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Interleukin-8
Sources: IL-8 is probably the best characterized C-X-C chemokine. IL-8 is
produced by macrophages, fibroblasts, endothelial cells, keratinocytes, melanocytes,
hepatocytes, chondrocytes, and a number of tumor cell lines [15].
Protein characteristics: IL-8 is a non-glycosylated protein of 8 kDa (72 amino
acids). It is produced by the processing of a precursor protein of 99 aminoacids [16]. The
three-dimensional structure of IL-8 has been determined by NMR spectroscopy and x-
ray crystallography (Figure 1) [31] [32].
Biological activities: The biological activities of IL-8 resemble those of a related
protein, NAP-2 (neutrophil-activating peptide-2). IL-8 increases Chemotaxis and the
enhanced expression of adhesion molecules [14]. IL-8 is chemotactic for all known types
of migratory immune cells. IL-8 is a mitogen for epidermal cells. Macrophage-derived
IL-8 supports angiogenesis and may play a role in angiogenesis-dependent conditions
such as rheumatoid arthritis, tumor growth, and wound healing [17].
Clinical significance: IL-8 may be of clinical relevance in psoriasis and
rheumatoid arthritis [18, 19]. Elevated concentrations are observed in psoriatic scales and
this may explain the high proliferation rate observed in these cells. IL-8 may be also a
marker of different inflammatory processes. IL-8 probably plays a role in the
pathogenesis of chronic polyarthritis since excessive amounts of this factor are found in
synovial fluids. IL-8 has been detected in the gingival crevicular fluid (GCF) and in
gingival tissue sections of adult periodontitis patients and IL-8 mRNA has been identified
in healthy and diseased periodontal tissues [20-23].
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CXC-receptors
Chemokines exert their biological functions via cell-surface receptors. Two
chemokine receptors, CXCR-l and CXCR-2, have been identified on human neutrophils
[24, 25]. CXC chemokines function as chemoattractants and activators of neutrophils
through high-affinity binding to at least one of the two receptors. It has been
demonstrated that CXCR-2 has a high affinity for IL-8 and all the other CXC
chemokines, while CXCR-l has a high affinity for IL-8 only [25]. These receptors are
present in a variety of cells, including neutrophils, monocytes, keratinocytes, endothelial
cells, fibroblasts, smooth muscle cells and T cells.
Epithelial cells and IL-8
The gingival mucosa is composed of three types of epithelium: oral gingival
epithelium, oral sulcular epithelium and junctional epithelium. The predominant cell type
in these epithelia is the gingival keratinocyte (or gingival epithelial cell). This cell shares
many properties with keratinocytes located in other types of stratified epithelia like
epidermis. These properties include replication and differentiation from a basal cell layer
and synthesis of cytokeratin [26]. However, the role of the gingival keratinocyte in
periodontal disease has been studied in a limited basis. This is not the case in
Dermatology, where the role of epidermal keratinocyte in psoriasis has been established.
Psoriasis is a chronic inflammatory disease of the skin, characterized by erythenlatous
scaling plaques, affecting the skin of the knees, elbows or scalp [27]. Psoriasis and
periodontitis share common histological characteristics, like the dense accumulation of
neutrophils and T-lymphocytes below the epithelium. An important characteristic of
psoriasis is the secretion of IL-8 by epidermal keratinocytes, which upregulates leukocyte
8
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CHAPTERl
Localization of interleukin-8 and interleukin-8
receptors in human gingival tissues and cultured human
gingival epithelial cells
ABSTRACT
Interleukin-8 (IL-8) belongs in the CXC chemokine family and is involved in
processes, such as leukocyte chemotaxis, inflammation, angiogenesis, wound healing and
tumor growth. It has been detected in the gingival crevicular fluid (GCF) and IL-8
mRNA has been identified in periodontal tissues. The existing literature is not conclusive,
however, about the exact source and localization of this cytokine in the gingival tissues.
Currently, nothing is known about the localization of IL-8 receptors in the gingiva.
Therefore, our purpose was to characterize the localization of IL-8 and IL-8 receptors in
gingival tissues and cultured human gingival epithelial cells.
We hypothesized that in vivo, periodontal pathogens induce IL-8 expression from
gingival epithelial cells (GEC). We further hypothesized that this local expression of
GEC derived IL-8 enhances leukocyte, vascular endothelial cell (VEC) and GEC
migration via specific IL-8 receptors present on these cells.
Standard immunohistochemical techniques were applied in order to localize IL-8
and its receptors, CXCR-I and CXCR-2, in archival specimens of gingival tissues from
periodontitis patients. Cultured gingival epithelial cells, were also examined, using
immunocytochemical techniques, for expression of IL-8 and IL-8 receptors. The results
of these studies demonstrated that both IL-8 and the receptors CXCR-l and CXCR-2 are
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present in gingiva, fact that supports our hypothesis. CXCR-1 and CXCR-2 were
expressed in the epithelium, microvascular endothelial cells and leukocytes within the
inflamed tissues. In vitro studies verified the above results, by showing expression of IL-
8, CXCR-1 and CXCR-2 in cultured epithelial cells.
It is concluded that IL-8 and the receptors CXCR-l and CXCR-2 are expressed in
the gingival epithelium both in vivo and in vitro. This suggests that epithelium plays
critical role in the host defense against invading pathogens. The existence of IL-8R
indicates that epithelial cells can actively respond to IL-8 and other host cytokines, like
GRO, and regulate their own cytokine functions. Understanding the mechanisms of
gingival chemokine expression against periopathogens will clarify the pathogenesis of
specific and non-specific bacterial infections of the periodontium.
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1. INTRODUCTION
Periodontitis is a common oral inflammatory condition in humans [1].
Periodontitis includes a group of clinical entities, that are generally characterized by a
dynamic influx of neutrophils and T lymphocytes, initially, and plasma cells in later
stages [2, 3]. CXC chemokines function as chemoattractants and activators of leukocytes.
They are involved in many processes, such as migration and release of leukocytes,
inflammation, angiogenesis, and tU.mor growth. Interleukin-8 (IL-8) belongs in the CXC
chemokine subfamily. IL-8 has been detected in the gingival crevicular fluid (GCF) and
both IL-8 and IL-8 m RNA have been identified, by our laboratory, in gingival tissue
sections of periodontitis patients [4-6].
To date there are two types ofIL-8 receptors: CXCR-1 and CXCR-2 [7]. They are
present in a variety of cells, including neutrophils, monocytes, keratinocytes, endothelial
cells, fibroblasts, snl00th nluscle cells and T cells. CXCR-l is highly specific for IL-8.
CXCR-2 is not highly specific for IL-8 and can bind other chenl0kines like MGSA
(Melanoma growth stimulatory activity) also known as GRO (Growth related oncogene),
MIP-2 (Macrophage inflammatory protein-2), and NAP-2 (Neutrophil-activating protein-
2).
It has been shown that IL-8 is mediating inflammatory and immune conditions
including psoriasis and rheumatoid arthriris [8-10]. Most of the documentation about
keratinocytes derives from epidermal keratinocytes and their role in psoriasis. Although,
there are histopathological and etiologic differences between psoriasis and periodontitis,
they share some common characteristics like the dense accumulation of T-cells and
PMNs beneath the epithelial layer. In both of these conditions there is a neutrophil-
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mediated tissue damage. This is also a characteristic of periodontitis. There are
contradictory views in the dental literature concerning the relation of IL-8 with the
inflammatory status of the gingiva.
IL-8 has been associated with increased gingival inflammation. We have
previously reported that interleukin-8 antigen and IL-8mRNA are elevated in inflamed
gingiva [6]. Tonetti et ai. detected IL-8mRNA in both healthy and diseased samples and
reported that the localization of cells expressing IL-8mRNA paralleled the PMN
infiltration of inflamed gingiva [5]. Finally, Dongari and Ebersole reported higher levels
of IL-8 in connective tissue from periodontitis patients versus healthy patients [11].
Mc Gee et aI., stated that IL-8 concentration is relatively higher in healthy gingiva
and that it becomes reduced as the periodontal disease progresses [12]. This concept is
also supported by Tonetti et aI., who reported that IL-8 gene transcription was detectable
at healthy sites, but was below detectable levels in 77% of the periodontitis sites [13].
Generally, little is known about the cells producing IL-8 in gingiva, or about their
mechanism and sites of production in vivo. IL-8 mRNA-expressing cells in inflamed
gingiva, were initially considered to be mainly macrophages [14]. Later, it was shown
that IL-8 secreting fibroblast subpopulations may play more important role in the total
IL-8 expression in inflamed tissues [11]. Localization of IL-8 within the gingival
epithelium has previously been demonstrated, by our laboratory. Tonetti reported that
periodontal pocket epithelium and junctional epithelium express IL-8 mRNA [5, 6].
Currently nothing is known about the expression of the IL-8 receptors (CXCR-l and
CXCR-2) in gingiva.
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In our study, we hypothesized that periodontal bacteria induce IL-8 expression in
gingival epithelial cells. We further hypothesized that this local expression of GEC-
derived IL-8 enhances leukocyte, vascular endothelial cell (VEC) and GEC migration via
specific IL-8 receptors (CXCR-l and CXCR-2).
In this chapter (Chapter 1) we determined the distribution of IL-8 and IL-8
receptors CXCR-l and CXCR-2 in human gingival tissues, using standard
immunohistochemical techniques. We also determined the localization of IL-8 and its
receptors in cultured GECs using standard immunocytochemical procedures.
Our results clearly demonstrate that IL-8 is predominantly localized in the
gingival epithelium, since 12/12 specimens stained positive. IL-8 receptor expression was
seen, in varying degrees in 12/12 specimens, on GECs, leukocytes, VECs and smooth
muscle cells and was increased in samples with inflammation. These findings support our
hypothesis that GECs are a source of IL-8 in vivo and in vitro and that epithelial-
expressed IL-8 enhances leukocyte, vascular endothelial cell (VEC) and GEC migration
via specific IL-8 receptors (CXCR-l and CXCR-2). Our study provides new evidence
showing that GECs are multifunctional units that interact with a variety of cells, causing
chemotactic, angiogenic and mitogenic signals.
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A. actinomycetemcomitans
Figure 1.1 Hypothetical model of IL-8 functions in the periodontal environment
Periodontal pathogens induce expression of IL-8 in GEes, which can either bind back to
the same cell, in an autocrine fashion, or act in a paracrine way. IL-8 can mediate
epithelial proliferation and repair, angiogenesis or leukocyte chemotaxis/inflammation.
Although inflammation aims to destroy the pathogen, it causes tissue destruction in the
same time, resulting in loss of periodontal attachment and alveolar bone. In this chapter
we are going to examine the localization of IL-8 and IL-8 receptors.
2. METHODS
2.1. Gingival biopsies
Paraffin-embedded gingival specimens (n=12) were obtained from the archives of
Oral Pathology, University of Connecticut Health Center. 8 out of 12 specimens were
originally obtained during periodontal surgery, from 8 patients, 3 males and 5 females
ranging from 31 to 67 years old. All the patients had undergone routine initial therapy,
which consisted of oral hygiene instructions and supra- and sub-gingival debridement.
Specimens were selected after histological review of hematoxylin-eosin stained slides to
contain both high degree of inflammation. 4 out of 12 were non-inflammed gingival
specimens used as controls. The paraffin-embedded tissue was cut into 4-um sections and
mounted on slides for further immunohistochemical evaluation.
2.2. Immunohistochemical technique
Immunohistochemical analysis of the tissue slides was performed for IL-8,
CXCR-1 and CXCR-2 antigen. The tissue was deparaffinized in xylene and rehydrated
sequentially in graded alcohol (100%, 95%, 70% and 50%). To inhibit endogenous
peroxidase, the sections were immersed in 100% methanol containing 0.01 % hydrogen
peroxide at room temperature (RT) for 20 minutes. Antigen unmasking using was then
performed. The slides were immersed in O.OIM sodium citrate at 90°C for 5 min and then
rinsed in PBS. This procedure unmasked the epitopes from formalin bonds, allowing
better antibody recognition. The sections were then blocked with 0.5% normal goat
serum (Vector, Burlington, California) at RT for 1 hour. The sections were then washed
x3 wit11 phosphate-buffered saline (PBS, pH 7.4) and then rabbit anti-human IL-8,
CXCR-1 or CXCR-2 (diluted of PBS with 0.5% goat serum) were added. Those primary
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antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz,CA) and used at
the following dilutions. For IL-8, 1:100, for CXCR-1, 1:25 and for CXCR-2, 1:800. An
equal concentration of goat non-immune IgG was used as control, to verify the specificity
of the antibody reaction. After incubation for 2h, biotinylated goat anti-rabbit antibody at
a 1:200 dilution in PBS with 0.5% goat serum, was applied to the sections and allowed to
incubate for one hour at RT. Sections were washed with PBS between each of the
following steps. HRP-streptavidin (Zymed,S.F.,CA) at a 1: 100 dilution PBS was applied
to the sections and incubated at RT for 45 minutes. Especially for IL-8 we used 1:400
poly-HRP-streptavidin. The sections were incubated sequentially with 3-amino-9-
ethylbarbazole in O.lM sodium acetate buffer (pH 5.2) and 0.03% hydrogen peroxide for
20 minutes at RT. Sections were then counter stained with Mayer's hematoxylin (Sigma,
St.Louis, Missouri) for 5 minutes, washed extensively in water, dipped in dilute
ammonium hydroxide and mounted in crystal mounting solution (Biomeda, Foster City,
CA). The flow diagram summarizes the procedure:
Gingival Tissue (N=12)
t
10% Formalin
~
Paraffin
t
Unstained Slides
t
@IL-8 or @IL-8R Antibodies or N IgG
~
Immunohistochemistry
t
Microscopic evaluation
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2.3. Culture of gingival keratinocytes and immunocytochemistry
The human gingival epithelial cells used were immortalized with the Human
Papilloma Virus type 16, the E6/E7 gene. The cell line was kindly provided by Dr. Oda,
Department of Oral Biology, University of Washington, Seattle. The cells were kept
frozen in liquid N2. Before every experiment the cells were thawed, plated into tissue
culture flasks (Falcon, Franklin Lakes NJ) and fed every 48 hours. The medium used was
Keratinocyte Serum-Free Medium (KSFM, Gibco).
The cells were grown up to the required number (3-4 x 106 cells) into 75 cm2
tissue culture flasks (Costar). They were trypsinized using 0.025% bovine trypsin in
0.01 % EDTA (Clonetics, Walkersville, MD). The cells were then plated into 4-well Lab-
Tek chamber slides (Marsh Bio Products,Rochester,NY) at a concentration of 5xl04cells/
O.5ml medium / well and were incubated for 6 hours in order to adhere and to reach a
confluence 60-70%. Then, they were fixed with 10% phosphate buffered formalin.
Immunocytochemistry was performed using the indirect immunoperoxidase staining
technique as in the immunohistochemistry procedure. However, all the steps of
deparaffinization and rehydration were omitted. The cells were immersed in 100%
methanol containing 0.01 % hydrogen peroxide at room temperature (RT) for 20 minutes,
in order to permeabilize the cell membrane and to allow assess of the antibodies into the
cytoplasm. The sodium citrate unmasking step was also omitted. The flow diagram below
describes the procedure:
GECs (PP cells)
~ 37°C, 5%COz
Slide Chambers
~
10% Formalin
~
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@ IL-8 or @ IL-8R Antibodies or N IgG
J,
Immunocytochemistry
J,
Microscopic Evaluation
2.4. Slide analysis
Slides were evaluated using light microscopy in magnifications ranging from 40x
to 600x using an Olympus Microscope. The degree of staining was graded on a scale of 0
to 3.
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3. RESULTS
3.1. Expression of IL-8 in gingival tissue and epithelial cells in vitro
3.1.1. IL-8 and gingival tissue
All the slides stained positive for IL-8. The anti-IL-8 antibody was localized
mainly in the epithelial layer of the gingival tissues. The intensity of antibody binding
was higher near the keratin layer and it was decreasing in a corono-apical direction
(Fig.l.2,a). On a scale of 0 to 3, the keratin and granular layer stained 3, the spinous layer
1-2 and the basal layer O. Therefore, the basal epithelial layer presented minimal IL-8
expression. Within the epithelium, there were areas with more intense staining than
others. The underlying stroma (connective tissue) and VECs showed little evidence of IL-
8 expression ranging from 0 to 1. The infiltrating il1flammatory cells stained for IL-8 with
a degree 1-2. The same samples were incubated with goat IgG, as specificity control, and
no staining was observed (Fig.l.2,b).
3.1.2. IL-8 and gingival epithelial cells
After demonstrating the localization of IL-8 in the gingival biopsies, we
hypothesized that IL-8 is produced locally and that GEes are the source of IL-8. In order
to test our hypothesis, we stained cultured GEC with anti-IL-8 antibodies. The color
difference was compared to the controls, where goat IgG was added instead of anti-IL-8
antibody. 100% of the cultured GECs stained positive for IL-8, with a degree 3 intensity
(Fig. 1.3, a). This presented as bright red color that occupied the cytoplasm, where the IL-
8 antigen was localized. The pattern of the staining was granular, indicating local
condensations of IL-8 antigen, which might correspond to either secretory vesicles or
membrane bound IL-8. This indicated that GECs express IL-8 in vitro.
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Figure 1.2 Immunohistochemical staining of gingival tissue for IL-8 expression
a: Gingival expression of IL-8 (red color) using anti-IL-8 antibody (200x). IL-8 antigen is
localized in the superficial epithelial layers. The epithelial surface is on the upper right
comer. b: Negative control staining using IgG in the same concentration as the specific
anti-IL-8 antibody (200x).
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Figure 1.3 Immunocytochemical staining of gingival epithelial cells (GEes) for IL-8
expression
a: GEe expression of IL-8 (red color) using anti-IL-8 antibody (600x).l00% of the cells
stained positive. b: Negative control staining using IgG (600x).
3.2. Expression of CXCR-l in gingival tissue and epithelial cells in vitro
3.1.1. CXCR-l and gingival tissue
The localization of CXCR-1 antigen was examined using anti-CXCR-1 antibodies
in 12 gingival biopsies. The specificity of the method was tested by incubating the same
samples with goat IgG. 100% of the samples (12/12) stained positive, but the intensity of
CXCR-1 antigen varied according to the degree of inflammation. Non-inflamed samples
presented degree 1 staining, whereas inflamed samples presented degree 2 staining (Fig
1.4, a). CXCR-1 antigen, in all the samples, was detected more in the keratin and granular
and less in the spinous layer of the epithelium, indicating CXCR-1 reduction in a corono-
apical direction. The basal layer of the epithelium, showed degree 0 staining, indicating
absence of CXCR-1 antigen. In inflamed samples, staining (degree 2) was also observed
in the underlining stroma, associated with inflammatory cells and extracellular matrix.
3.1.2. CXCR-l and gingival epithelial cells
Imnlunocytochemicallocalization of CXCR-1 antigen was performed in cultured
GECs. All the cells stained positive for CXCR-1 (Figure 1.5, a). The intensity of the
staining was between 2-3 and was more diffuse compared to IL-8 staining. No staining
was seen in the negative control slides (Fig.1.5, b) indicating the specificity of CXCR-1
staining technique.
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3.3. Expression of CXCR-2 in gingival tissue and epithelial cells in vitro
3.3.1. CXCR-2 and gingival tissue
The localization of CXCR-2 was examined using anti-CXCR-2 antibodies. The
specificity of the procedure was tested by incubating the sanlples with goat IgG. 100% of
the samples stained positive for CXCR-2, with a degree of staining ranging between 2-3.
Again, similar to CXCR-l, non-inflamed samples (based of the degree of inflammatory
infiltration) stained less intense (degree 2) than inflamed (degree 3). In all the samples,
CXCR-2 antigen was detected in the gingival epithelium and the underlying stroma.
Within the epithelium, the more intense staining was seen in the apical part of keratin
layer and the spinous and granular layers. No staining was seen in the basal layer. Within
the stroma, significant staining was associated with leukocytes, smooth muscle cells and
microvascular endothelial cells (MVEC), especially in the areas with dense inflammatory
infiltrates (Fig.l.6, c). It shollid be noted that the antibody concentration that we used for
CXCR-2 was 32 times lower that the anti-CXCR-l antibody, in order to obtain the
similar degree of staining.
3.3.2. CXCR-2 and gingival epithelial cells
In order to test the hypothesis that the CXCR-2 antigen derives from the epithelial
cells, immunocytochemical localization of this antigen was performed in cultured GECs.
CXCR-2 were found in 100% of the cells (Fig.l.7, a). The distribution of the receptors
presented a unique pattern. Although they were seen throughout the cytoplasm, there was
a more intense staining in the perinuclear area, especially in fully developed cells. No
staining was seen in the negative control slides (Fig.l.6, b), indicating the specificity of
the technique for CXCR-2 binding.
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4. DISCUSSION
Localization of IL-8 in gingival tissues
IL-8 is a chemotactic cytokine for all known types of migratory immune cells. IL-
8 is a mitogen for epidern1al cells. IL-8 has been implicated in angiogenesis and may play
a role in angiogenesis-dependent conditions such as rheumatoid arthritis, tumor growth,
and wound healing. IL-8 may be also a marker of different inflammatory diseases. IL-8
may be of clinical relevance in psoriasis. Elevated concentrations are observed in
psoriatic scales and this may explain the high proliferation rate observed in these cells.
IL-8 mRNA levels were shown to correspond to the severity of periodontitis [5] but its
role(s) and source(s) in periodontal disease are not clearly understood.
We hypothesized that in vivo, periodontal pathogens release factors that induce
IL-8 expression from gingival epithelial cells (GEC). We further hypothesized that this
local expression of GEC-derived IL-8 enhances leukocyte, vascular endothelial cells
(VEC) and GEC migration via specific IL-8 receptors present on these cells. Therefore,
our aim was to characterize the in vivo IL-8 and IL-8 receptor expression in tissues from
patients with periodontal disease; we also studied the localization of IL-8 and IL-8
receptors in gingival epithelial cells, in vitro.
The epithelial localization of IL-8 was demonstrated in our study. In all biopsies
the IL-8 antigen was found within the spinous, granular and apical part of keratin layer.
Minimal or no staining was seen in the basal layer and in the underlying connective
tissue. There was some variation, however, in the intensity of the staining. This possibly
reflects inter-patient variation in the degree of inflammation or in the degree of cytokine
response to the bacterial challenge [11]. Where the connective tissue was inflan1ed, large
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"rete" processes were observed. No polymorphonuclear leukocytes were seen within the
epithelium. However, where the normal epithelial structure was altered, GEes showed
strong positive reaction for IL-8, suggesting that IL-8 might have biological activity
within the epithelium and it might contribute to the observed epithelial proliferation.
The localization of IL-8 has been studied by Fitzgerald and Kreutzer [6]. They
found that both interleukin-8 antigen and mRNA are elevated in chronically inflamed
gingiva and that interleukin-8 antigen is detected only in the epithelial cell layer, which is
consistent with our findings. Me Gee et al., on the other hand, have stated that IL-8
concentration is relatively higher in healthy gingiva (compared to IL-6) and that it
becomes progressively reduced as the gingival sulcus increases in depth and the
periodontal disease progresses [12]. This concept is also supported by Tonetti et aI., who
reported that IL-8 gene transcription was detectable at healthy sites, but was below
detectable levels in 77% of the periodontitis sites [13]. The same author has also
examined the localization of IL-8 mRNA+ cells in samples from healthy and periodontal
sites, in another publication the following year (1994) [5]. They reported that IL-8 m
RNA positive cells were found in the junctional and pocket epithelium, bllt not in the
inflamed connective tissue. In the healthy and gingivitis specimens the number of
positive cells increased in an apico-coronal direction and was maximal in the superficial
layers. In the periodontitis specimens, the positive cells were prominent in the pocket
epithelium, adjacent to the infecting plaque organisms. PMNs were found mainly in the
junctional epithelium, pocket epithelium and in the underlying connective tissue. They
also observed that IL-8 expression, in general, paralleled PMNs infiltration. Matsuki et aI.
have identified the IL-8 mRNA expressing cells, in inflamed gingiva, mainly as
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macrophages [14]. The authors reported a lower IL-8 mRNA expression in endothelial
cells and fibroblasts, but gave to data about epithelial cells.
From the above data, it is suggested that GECs form a barrier between the oral
environment and the underlying connective tissues and they modulate the leukocyte
infiltration and activation by producing IL-8 after interaction with periodontal pathogens
like A. actinomycetemcomitans. Since IL-8 has also been detected in healthy gingiva, it
may playa role in the constant migration of neutrophils through the gingival tissues and
in the establishment of equilibrium between the continuous bacterial challenge and the
host defenses.
Localization of IL-8 in cultured gingival epithelial cells
Although several investigators have studied the localization of IL-8 in gingival
tissues the localization of IL-8 in gingival epithelial cells (GECs) in culture has not been
reported to date. After demonstrating the epithelial expression of IL-8 in gingival
biopsies, we wanted to further examine the localization of IL-8 on GECs. We
hypothesized that GECs are genetically programmed to produce IL-8 as part of innate
immunity. Using standard immunocytochemical procedures we showed that IL-8 antigen
is, indeed, expressed in a gingival epithelial cell line, whether the cells are exposed to
pathogens or not. IL-8 could be in two possible compartments: 1) Intracellular, since the
cell membranes were permeabilized with methanol or 2) membrane-bound (connected
with IL-8 receptors).
The localization of IL-8 can be seen in the Figure 1.3 and is characterized as
diffuse, although in higher magnification some localized condensations were observed.
We postulated that part of the excreted IL-8 binds back to its receptors in GECs initiating
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an autocrine loop. We have demonstrated that both of the IL-8 receptors (CXCR-l and
CXCR-2) are present in GECs and therefore our hypothesis for autocrine regulation and
IL-8-induced epithelial cell proliferation can be valid.
Localization of IL-8 receptors in gingival tissues
The receptors that bind C-X-C Chemokines are designated CXCR followed by a
number (e.g. CXCR-l, CXCR-2, CXCR-3 etc.). Both IL-8 and GRO belong in that
cytokine family. To date there are two types of IL-8 receptors that have been isolated,
characterized and cloned: CXCR-l and CXCR-2 [7]. IL-8 receptors (previously called
IL-8RA and IL-8RB) are present in a variety of cells. Neutrophils, monocytes,
keratinocytes, endothelial cells, fibroblasts, smooth muscle cells and T cells have been
shown to express one or both of these receptors. The receptors show 77% amino acid
sequence homology between themselves. CXCR-l is highly specific for IL-8. CXCR-2 is
not specific for IL-8 and also binds other chemokines like MGSA (Melanonla growth
stimulatory activity) also known as GRO (Growth related oncogene), MIP-2
(Macrophage inflammatory protein-2), and NAP-2 (Neutrophil-activating protein-2). In
neutrophils, the affinity of CXCR-2 for IL-8 is 2-5 times greater compared to that of
CXCR-l. It has been proposed that the 2 receptors have different fUl1ctions. In
neutrophils, CXCR-2 may playas active role in the initiation of migration distant from
the site of inflammation, where the concentration of IL-8 is at the picomolar level. The
low affinity CXCR-l may playa more active role in mediating IL-8 signal at the site of
inflammation, where the concentration of IL-8 is high.
We have shown that IL-8 is present within the periodontal microenvironment and
specifically in the oral epithelium. We then hypothesized the existence of IL-8 receptors
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in GECs, VECs and leukocytes, which means that those cells are responsive to IL-8
stimulus. We examined the existence and distribution of IL-8 receptors in the same
gingival samples that we used for IL-8 localization. It is clear from our results that both
IL-8 receptors are expressed in gingival tissues. The existence of those receptors has also
been shown in samples from head and neck squamous cell carcinoma by Richards et al
[15].
Expression of both CXCR-l and CXCR-2 was detected within the epithelium,
with the exception of the basal layer. The basal epithelial layer lacked staining for
CXCR-l or CXCR-2 in all the gingival samples that we examined. Intense staining for
CXCR-2 was seen in microvascular endothelial cells (MVECs), and smooth muscle cells
in 100% the gingival biopsies. However, MVEC staining for CXCR-l was only seen in
50% of the gingival samples, and was less intense. The MVEC staining was the major
difference between the patterns seen with the two receptors. This finding was in
agreement with Richards et al [15]. They reported that 93% of oral tissues had positive
MVEC staining for CXCR-2, but only 42% had positive staining for CXCR-l.
Another difference that we observed was the different amount of antibody that
was required in order to stain the 2 receptors in the gingival samples. For the receptor
CXCR-l we used 32 times higher concentration of antibody (8 ug/ml) than for the
receptor CXCR-2 (0.25 ug/ml). Although we cannot directly compare the efficacy of 2
different antibodies, there is a suggestion that receptors CXCR-2 are more prominent in
gingival tissues.
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Localization of IL-8 receptors in cultured gingival epithelial cells
After demonstrating the presence of the receptor antigen in gingival biopsies, we
hypothesized that GECs in culture also express both receptors of IL-8. We showed that
CXCR-l and CXCR-2 antigens are, indeed, expressed in the gingival epithelial cell line
PP. The localization of CXCR-l can be seen in the Figure 1.5 and is characterized as
diffused and equally distributed. Localization of CXCR-2 was different with apparent
perinuclear condensations. However, it is difficult from the 2-dimenssional images to
determine the exact location of the receptors. We were not able to define with certainty
whether the receptors were located intracellular, or on the plasma membrane. Future
studies should aim in this direction. Clarifying the exact location of IL-8 receptors could
help understanding the regulatory events that take place after IL-8 excretion.
It can be concluded from our data that the gingival epithelium participates
actively in inflammatory processes. IL-8 is expressed by GECs during inflammation and
regulates PMN chemotaxis, angiogenesis and epithelial proliferation and expression of
IL-8 in an autocrine fashion. It is the first time that the expression of IL-8 receptors has
been characterized in human gingiva. It was shown that CXCR-l and CXCR-2 are
expressed in gingival epithelial cells, MVECs, leukocytes and smooth muscle cells
Fig.l.8). The present studies clearly support our hypothesis that GEC are a source of IL-8
in vivo and in vitro and that epithelial produced IL-8 plays a multifunctional role in the
periodontal tissues. Future studies are needed to determine the clinical relevance of these
observations and the future therapeutic applications that they might have.
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-Leukocytes -Leukocytes
-SmoothMC LEUKOCYTES
Figure 1.8 Summary of immunohistochemistry and immunocytochemistry
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CHAPTER 2
Characterization ofA. actinomycetemcomitans-induced
interleukin-8 from gingival epithelial cells
ABSTRACT
Periodontitis is a group of inflammatory conditions that result mainly from the
interaction of pathogenic microorganisms with the periodontal tissues. Gingival epithelial
cells are the first cells of the host that encoul1ter the bacterial challenge and therefore
their role in the initiation of the immune response is critical. Among the periodontal
pathogens, Actinobacillus actinomycetemcomitans (A.a.) is a key microorganism that
adheres to and invades oral epithelial cells. Currently there is limited knowledge about
the role of gingival epithelial cells in the initiation of host defense after encountering
A.a..
We hypothesized that sonicated extracts of this bacterium would be able to
upregulate IL-8 expression by GECs. We further hypothesized that the IL-8 expression
induced by this pathogen is mediated by MAP kinase in the intracellular level. Finally,
we examined whether the A.a.-induced upregulation of IL-8 by GEes is related to the
A.a.-derived LPS.
An oral epithelial cell line was co-cultured with A.a. sonicated extracts at various
concentrations and for various time periods. The supernatants were collected for IL-8
detection with ELISA. For the MAP kinase studies, a potent inhibitor of p38 MAP kinase
(SB203580) was added in the cell cultures and 18 hours later the supernatants were
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assayed for IL-8. For the LPS studies, Polymyxin B was used to neutralize the LPS
content of the bacterial sonicates before stimulating GECs.
Dose-response studies showed that the highest IL-8 secretion was at the dose of
SOug/ml of A.a. protein. Time-course studies revealed that IL-8 secretion reached a
maximum level 24 hours after A.a. challenge and remained at those levels until 48 hours.
We found that the specific p38 MAP kinase inhibitor inhibited A.a.-induced IL-8
expression, but did not inhibit IL-lbeta-induced IL-8 expression. It was also found that
the ability of A.a. sonicates to induce IL-8 in epithelial cells was not diminished by
Polymyxin B neutralization of LPS, which means that the stimulatory potential of A.a.
was not due to the LPS content of the sonicated extracts. In addition, it shown that E. coli
lipopolysaccharide (LPS), which was able to stimulate IL-8 release from peripheral blood
mononuclear cells (PBMC), did not release IL-8 from gingival epithelial cells.
These data indicate that gingival epithelial cells are capable of upregulating IL-8
expression in response to A.a. and thus may facilitate the recruitment of neutrophils as a
host defense mechanism. Our findings provide new evidence on the mechanism
responsible for the upregulation of IL-8. It was clearly shown that p38 MAP kinase is
involved in the signal transduction pathway that regulates A.a.-induced IL-8 expression.
It is concluded that other factors than A.a. LPS are responsible for the up-
regulation of the IL-8 expression in GEes. These might include polysaccharides, surface-
associated material (SAM), lipid A-associated proteins (LAP), porins, fimbriae and cell
wall polymers (CWP). The ability of A.a. to elicit IL-8 release from gingival epithelial
cells may be important in the pathogenesis of periodontal conditions. Knowledge of the
host and bacterial factors that induce IL-8 expression in GECs may be used in the future
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for modification of cytokine expression, as part of a preventive or therapeutic protocol of
periodontal conditions.
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1. INTRODUCTION
Bacterial induced IL-8 expression
Periodontitis is a group of inflammatory conditions elicited mainly by bacterial
colonization of the gingival sulcus. Normally, gingival epithelial cells form a barrier that
prevents microbes from invading internal periodontal tissues like periodontal ligament,
connective tissue and alveolar bone. However, Actinobacillus actinomycetemcomitans
(A.a.), an important periodontal pathogen, has been shown to invade oral epithelial cells
and has been implicated in forms of periodontal disease like Localized Juvenile
Periodontitis (LJP) and adult periodontitis (AP) [1-3]. Oral epithelial cells, as part of the
bacterial-host interaction, have been shown to produce several cytokines, including the
potent chemoattractor Interleukin-8 [4, 5]. IL-8 belongs in the family of Chemokines.
Chemokines are a family of small polypeptides that have chemoattractant properties for
inflammatory cells [6] and act as a signal for the emigration of blood cells. Several
reports have suggested that cytokines, including IL-8, play important roles in the
pathogenesis of periodontitis [7, 8].
Interleukin-8 (IL-8) is one of the C-X-C chemokines, which are considered the
most important mediators of the accumulation of granulocytes [9]. IL-8 has been detected
in the gingival crevicular fluid (GCF) [10] and in gingival tissue sections of adult
periodontitis patients [11] and IL-8 n1RNA has been identified in healthy and diseased
periodontal tissues [12, 13]. Several studies have shown that unstimulated oral
keratinocytes, in culture, have a detectable basal IL-8 expression. Formanek et al. [14]
and Li et al showed that resting cultured normal oral keratinocytes produced small
amounts of IL-8 [15].
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It is currently known that vital bacteria (in-vitro) can upregulate the basal IL-8
production of oral keratinocytes. Vernier et al. have shown that Streptococci viridans are
potent stimulators of interleukin-8 production by a human oral epithelial cell line (KB
line) [16]. It has been shown that KB cells upregulate their basal IL-8 production
following infection with the periodontopathic bacterium Eikenella corrodens, too [17]. It
should be noted that bacterial invasion or even adhesion is not always necessary for
cytokine up-regulation. Yumoto et al examined how adhesion of the bacterium affects the
cytokine produced by epithelial cells [17]. The results of this study suggest that the direct
contact of E. corrodens with oral epithelial cells is not necessarily required for the
stimulation of IL-8 expression.
Infection with non-vital bacteria can also induce proinflammatory cytokine
expression. Huang et ale demonstrated that IL-8 expression of both primary and
immortalized oral keratinocytes is upregulated after in-vitro infection with vital and non-
vital A.a. [5]. The highest IL-8 expression was at the multiplicity of infection (MOl) of
1,000: 1 with vital A.a. Time-course studies revealed that IL-8 expression rapidly reached
a maximum level 6 hours after bacterial infection. 24 hours after vital bacterial challenge
a 7-fold increase was demonstrated in the IL-8 expression. In an other publication by the
same author it was shown that dead strains of P. gingivalis can induce more IL-8
secretion by human gingival epithelial cells compared to live strains [18]. These data
indicate that oral epithelial cells are capable of upregulating IL-8 expression in response
to bacterial challenge and thus may facilitate the recruitment of neutrophils as a host
defense mechanism.
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In our study we hypothesized that sonicated extracts of A.a. upregulate IL-8
expression in GECs. We exposed GEes, in vitro, to the bacterial stimulus at various
concentrations and for various time periods. The medium was then collected and assayed
for interleukin-8, using ELISA. The results indicated a dose-dependant relation if IL-8 to
the bacterial concentration, up to a ll1aximum of 50ug/ml. Higher concentrations of A.a.
caused reduction of IL-8. The kinetic study revealed that IL-8 is secreted as early as 2h
after the bacterial exposure, peaks at 24h and remains stable until 48h. That corresponded
to a 7-fold increase compared to the unstimulated cells.
The above findings support our hypothesis about the role of GECs. They show
that vitality of bacterial stains is not required for immune response, since bacterial
products can activate cytokine responses. This has significant implications in clinical
periodontics because we have demonstrated that killing the periopathogens is not enough
for the elimination of periodontitis. Bacterial products that remain in the periodontal
pocket can activate immune responses with detrimental consequences for the
periodontium.
The role of gingival keratinocyte was also stressed. Their immediate chemokine
response seems to be critical for neutrophil influx and activation against the invading
pathogens.
MAP kinase mediation of IL-8 expression
At present, little is known about the mechanisms by which A.a. induces the
expression of pro-inflammatory cytokines in the cellular level. A number of recent
studies implicate mitogen activated protein (MAP) kinases in the signal transduction
patl1way of IL-8 expression by several different cell systems like intestinal epithelial cells
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[19], bronchial epithelial cells [20-22] and leukocytes [23, 24]. MAP kinases are a family
of cell signaling molecules [25-27]. MAP kinases can be activated by a wide variety of
extracellular stimuli and transmit signals from the cell surface to the nucleus to regulate
gene expression. Cellular functions that are regulated, at least in part, by MAP kinases
include cell proliferation, cell survival, and cytokine production. There are three main
groups of MAP kinases [25-27] :
• the p38 kinases
• the extracellular signal-regulated kinases (ERK),
• the c-Jun N-terminal kinases (JNK).
These MAP kinase subfamilies form three parallel cascades that can be activated
simultaneously or independently. P38 and JNK are stimulated by inflammatory cytokines
and stress stimuli, but minimally by growth factors. ERK are strongly activated by
growth factors, but weakly by inflammatory stimuli.
There is no information to date about MAP kinase mediation of cytokine
expression on oral-derived cell systems and specifically gingival epithelial cells. We
hypothesized that A.a.-induced expression of IL-8 in GECs is mediated by p 38 MAP
kinase
The specific inhibitor of p38 MAP kinase SB 203580 was used to elucidate the
biologic function of p38 MAP kinase in A.a.-induced IL-8 expression. The inhibitor was
added to the cell cultures prior to the bacterial challenge. The IL-8 expressed by GECs
was then determined. SB 203580 significantly reduced IL-8 expression in A.a.-stimulated
cells, in a dose-dependent way, whereas it did not affect IL-8 production in unstimulated
cells. These results support our hypothesis and showed that A.a. interaction with GECs
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induced activation of p38 MAP kinase, which in turn, mediated IL-8 expression and
protein production and excretion. Understanding the intracellular mechanisms of IL-8
regulation is of great interest, as it may lead to the development of novel therapeutic
approaches for periodontitis, in addition to the traditional scaling and root planing and
periodontal surgery.
Virulence factors of A.a. that induce cytokines
In this study it was shown that A.a. sonicates are able to induce IL-8 expression
and that viability of A.a. was not necessary for the pathogenicity of this bacterium. The
question remains however: "What is the virulence factor of A.a. that upregulates GEC IL-
8 expression?" In the past many authors considered lipopolysaccharide (LPS) as the
major pathogenic substance. LPS is an integral component of the Gram-negative bacterial
outer membrane [28]. If released into the systemic circulation, LPS activates specialized
inflammatory cells to secrete proinflammatory cytokines including interleukin-l (IL-l),
tumor necrosis factor alpha (TNFa) and IL-6. In the serum, LPS binds LBP (LPS binding
protein) and is transferred to the cellular receptor CD14 [29]. Even cells without this
receptor can be activated by LPS, because soluble CD14 in serum can bind LPS and LBP
[30]. However, the potent effects of LPS on monocytes and macrophages, cannot be
generalized to other sites or cells in the infected host [31] .
It is only during in the past decade that the concept has arisen that bacterial
derived molecules, other than LPS, can induce cytokine expression. A large nUITlber of
components and products have been investigated for their ability to stimulate cytokine
release by mammalian cells and especially peripheral blood mononuclear cells (PBMCs)
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and fibroblasts. Some of these components have been proven to be more potent than
LPS. It is clear from the current literature that oral bacteria contain lipid A-associated
proteins, capsular polysaccharides, fimbriae and cell wall polymers (CWP). We are going
to review, briefly the basic pieces of evidence about the virulence factors of
periopathogenic bacteria.
Serotype specific A.a. polysaccharides have been shown to stimulate IL-I release
from murine macrophages [32]. Yamaguchi et al. stimulated human monocytes with
serotype b-specific polysaccharide antigen (SPA) from A.a. SPA increased the released
of IL-I, IL-6, TNF-a and the mRNA expression of IL-Ia, IL-I~, IL-6, TNF-a and IL-8
[33].
Saline-extractable surface-associated material (SAM) from A.a. is, according to
Reddi et aI, a potent cytokine-stimulating agent in stimulating IL-6 release by PBMCs
[34]. The same authors showed that lipid A-associated proteins (LAP) from A.a. had
cytokine stimulating activity in cultures of human gingival fibroblasts (HOFs) and human
PBMCs. A.a. LPS was less potent than the other surface extracts in stimulating release of
IL-I beta, IL-6 and TNF-alpha. LAP and LPS from periopathogens stimulate IL-6 release
from human gingival fibroblasts in a dose-dependent manner, although LPS is less potent
than LAP [35]. Others have shown that porins of gram negative bacteria are able to
induce the release of tumor necrosis factor alpha (TNF-a), interleukin-l alpha (IL-Ia),
and IL-6 by human monocytes and of gamma interferon (IFNy) and IL- 4 by human
lymphocytes [36].
Tani et al. found that extracellular antigens of A.a. contain a 37-kDa protein. This
protein induced IL-I~, IL-6, and TNF-a release from murine macrophages. The IL-6-
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inducing activity of the 37-kDa protein was higher than that of LPS. They concluded that
the 37-kDa protein plays a significant role in A.a.-associated periodontitis [37].
Fimbriae from periodontal pathogens have been shown to induce IL-6 and TNFa
from PBMCs [38]. It has also been demonstrated that IL-8 response of human
uroepithelial cells to P-fimbriated E. coli is CD14 and LPS independent, and that
attaching pathogens can overcome the LPS unresponsiveness of epithelial cells by
fimbriae-dependent activation mechanisms [31, 39]. Woolverton et aI, found that an
LPS-free cell wall polymer (CWP) preparation from A.a. was able to stimulate IL-l from
mouse splenocytes. That preparation appeared to consist of peptidoglycan, carbohydrates
and proteins [40].
An association between attachment and virulence has been suggested for the
periothogenic organisms A.a. and Porphyromonas gingivalis (P.g.) [41] It has been
shown, however, that non-vital bacteria are able to trigger cytokine response as well,
which implies that invasive ability is only responsible for part of the pathogenicity and
that dead bacteria can initiate a similar responses [5]. Our data also support this concept
since we have shown high levels of cytokine expression in response to sonicated extracts
fromA.a..
It has been postulated that the ability of Gram-negative pathogens to trigger
cytokine expression by epithelial cells may relate to other bacterial components than LPS
[31]. Most of the data that we have are derived from bronchial epithelial and uroepithelial
cell models. Palfreyman et al have demonstrated that B. cepacia lipopolysaccharide,
which was able to stimulate IL-8 release from monocytes, did not release IL-8 from a
bronchial epithelial cell line [39].
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Based on the above, we hypothesized that A. a. LPS is not necessary for
upregulation of IL-8 expression by GEes. Polymyxin B was used to neutralize the LPS
content of the bacterial sonicates before stimulating GECs. We also used PBMCs as
controls for LPS stimulation. Our results showed that LPS is a major factor in the PBMC
IL-8 expression, but not in the gingival epithelial cells. Other bacterial factors may play
more important role in the initiation of proinflammatory cytokine response. However, we
believe that more studies are necessary in epithelial cells in order to elucidate the
cytokine stimulatory components periodontal pathogens like A.a.
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Cytokine Bacterial component Cells References
Human Monocytes [33,36]
IL-la LPS 1, fimbriae, SPA2, porins Murine Splenocytes [40]
Murine Macrophages [32,37]
LPS, fimbriae, polysaccharides, HGFs5 [34]
IL-lf3 LAp3, SAM4, SPA, 37kDa Human Monocytes [33]
protein HPBMCs [34]
HPBMCs [34,38]
LPS, LAP, SAM, fimbriae, SPA, HGFs [34,35,42]
IL-6 porins, 37kDa protein Human Monocytes [33,36]
Murine Macrophages [37]
Human Monocytes [33,39]
IL-8 LPS, fimbriae, SPA Human Uroepithelial [31]
Human Monocytes [33,36]
LPS, LAP, SAM, porins, SPA, Murine Macrophages [37,43]
TNFa 37kDa protein, fimbriae HPBMCs [34,38,44]
HGFs [34]
Table 2.1 Proinflammatory cytokine expression induced by various bacterial
components
This table summarizes the bacterial virulence factors that can induce cytokine responses.
1 Lipopolysaccharides
2 Serotype b specific Polysaccharide Antigen (from A. actinomycetemcomitans)
3 Lipid A-associated Proteins (from A. actinomycetemcomitans)
4 Saline-extractable Surface-associated Material (from A. actinomycetemcomitans)
5 tIuman Gingival Fibroblasts
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2. METHODS
2.1. Culture of gingival keratinocytes
For our experiments we used human gingival epithelial cells immortalized with
the Human Papilloma Virus type 16, the E6/E7 gene [45]. The cell line was kindly
provided by Dr. ada, University of Washington, Seattle. The cells were kept frozen in
liquid N2. Before every experiment the cells were thawed, plated into tissue culture flask
(Falcon, Franklin Lakes NJ) and fed every 48 hours. The gingival epithelial cell line was
maintained in Keratinocyte Serum Free Medium (KSFM, Gibco BRL Life Technologies)
supplemented with penicillin-streptomycin and amphotericin B. The cells were grown up
to the required number (3-4 x 106 cells) into 75 cm2 tissue culture flasks (Costar). They
were trypsinized using 0.025% bovine trypsin in 0.01 % EDTA (Clonetics, Walkersville,
MD). The cells were then plated into 12-well tissue culture plates (Costar, Cambridge,
MA), 2 x 105 cells, in 1 ml medium per well, and were incubated for 4-6 hours in order to
adhere and reach confluence. Then, they were exposed to either A.a., or medium only.
There were triplicate wells for each condition. Cell cultures were maintained at 37°C and
5% CO2 • At the end of every experiment, the supernatants were collected, centrifuged
and assayed for IL-8. After the supernatants were collected, the cells were solubilized
using 0.1 % Triton, centrifuged and the ceillysates were assayed for cytokines.
2.2. Preparation of PBMC
Venous blood was collected from a healthy donor (A.S.) in 60 ml syringes
containing 5 ml Na-citrate 3.8%. Briefly, 20 ml aliquots of blood were mixed with an
equal volume of PBS. 35 ml of the blood-PBS suspension was carefully layered onto 15
ml of Ficoll-Paque (Pharmacia) and centrifuged at 450 g for 30 min at room temperature.
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The mononuclear cell layer was collected into Falcon tubes, washed with PBS and
centrifuged at 500 g for 15 min. The wash step was repeated and the pellet resuspended
in RPMI-1640 medium containing 1% Fetal Calf Serum. Following assessment of cell
viability by trypan blue, 1ml PBMC cultures in triplicate were established in 24-well,
flat-bottom microtiter plates (Falcon) at approximately 106 cells/well. Plates were
incubated for 2 h, washed with normal saline to remove non-adherent cells and then 1nl1
medium containing bacterial constituents with or without polymyxin B, was added to the
cells. The PBMCs were stimulated for 24 h at 37°C in an atmosphere of 5%C02 and 95%
air. Following culture, supernatants were collected, centrifuged and stored at -700 C for
use in cytokine quantitation studies. The flow diagram summarizes the procedure:
A.a. Extract or E.coli LPS or Media
~
±Polymyxin B
~
PBMCs
~ 24h, 37°C, 5%C02
Supematants/Lysates
~
IL-8 (ELISA)
2.3. A.a. challenge
A.a. strains (ATCC 33384), were kindly provided by Dr. Zadeh, University of
Southern California School of Dentistry, Los Angeles CA, USA. The bacteria were
grown for two 3-4 day periods and subcultured after each growth period to ensure strain
purity. Cells were harvested by washing and suspension in 3 ml sterile phosphate
buffered saline (PBS), followed by sonication to extract soluble bacterial components.
Briefly, cells suspended in PBS were subjected to 10 repetitions of sonication at 5-minute
intervals at a 10% duty cycle. The cell free supernatant was then collected by
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centrifugation at 8000 rpm for 30 minutes at 4° C and dialyzed with sterile PBS at 4° C.
Bacterial protein concentration was determined by Bradford protein assay (Bio-Rad,
Richmond CA). The extracts were aliquoted and stored at -70°C. Sonicated extracts
were used as bacterial challenge in various concentrations in the culture medium. The
flow diagram below describes the procedure:
A.a. (Dr. Zadeh, USC)
~
Grow for 3-4 days
~
Sonicate: 5min x 10
~
Spin: 8000 RPM, 30min
~
Dialysis with PBS
~
A.a. Protein Determination
(Bradford Assay)
~
A.a. Extracts
2.4. Treatment of GEes with specific p38 MAP kinase inhibitor
The aim of this study was to determine whether activation of p 38 MAP kinase is
required for A.a.-mediated IL-8 production. Cell culture experiments were conducted in
96-well polypropylene tissue culture plates (Corning Costar, Cambridge, MA). The
bacterial challenge consisted of A.a. sonicates with protein concentration 20 ug/ml. The
sonicates were prepared from A.a., strain ATCC 33384, as described in section 2.3.
For the blockade of p38 MAP kinase we used the specific p38 MAP kinase
inhibitor SB 203580 (Calbiochem, La Jolla, CA) It is a pyridinyl-imidazole compound,
the properties of which have been described in the literature [27, 47, 48]. The gingival
epithelial cells were treated with the specific p38 MAP kinase inhibitor for 60 min before
exposure to A.a. and during the incubation period of the experiment. The MAPK inhibitor
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was added at progressively increasing concentrations ranging from 0 to 100 uM.
Specifically, the following concentrations were used: 0,0.1,0.3, 1,3, 10,30 and 100 uM.
The cells were incubated for 18 hours and the culture supernatants were then harvested,
centrifuged and stored at -20°C until assayed. The flow diagram describes the procedure:
GEes
J,
12-well Plates
J,
±p38 MAPK Inhibitor
J,
A.a. Extract or rhlL-1beta or Media
J, I8h / 37°C, 5%C02
SupernatantslLysates
J,
IL-8 ELISA
2.5. LPS stimulation and neutralization of LPS
LPS fronl Escherichia coli 011l:B4 was purchased from Sigma Chemical,
St.Louis, MO. It was prepared by phenolic extraction and gel filtration chromatography.
LPS was diluted in the culture medium at various concentrations. Cells were grown until
confluent (approximately 4 xlO 4 cells/well) in 96-well plates. Test agents (A.a. sonicates
and purified E. coli LPS) were added to replicate wells, in the presence or absence of
Polymyxin B (purchased from Sigma Chemicals) and the cultures were incubated for 24h
before collection of cell supernatants. For neutralization of LPS activity, the stimuli E.
coli LPS and A.a. sonicates were incubated for 30 minutes with Polymyxin B before
every experiment. The flow diagram describes the set-up:
A.a. Extract or E. coli LPS or Media
J,
±Polymyxin B (100ug/ml)
J,
Add to GECs
J, 24h, 37°C, 5%C02
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.l-
SupematantslLysates
.l-
IL-8 ELISA
2.6. Measurement of IL-8
Quantification of IL-8 was accomplished using a matched pair enzyme-linked
immunoassay (ELISA) (Endogen Inc. Cambridge MA). Measurement of cytokine
expression by gingival keratinocytes was conducted on supernatants taken from cultures
subjected to various conditions of stimulation and duration of culture. Briefly, 96 well
assay plates were treated for 12 hours with 2 ug/ml mouse anti-human IL-8 monoclonal
coating antibody (Endogen Inc. Cambridge MA). Then, blocking buffer was added for
one hour, followed by 1 hour incubation with 25 ul aliquots of gingival keratinocyte
culture supernatant. Assay plates were then incubated with biotinylated mouse anti-
human IL-8 monoclonal detecting antibody at O.lg/ml and linked to horseradish
peroxidase-conjugated streptavidin (Zymed Laboratories Inc. San Francisco CA). Assay
plates were then incubated with tetramethylbenzidine (TMB) substrate (Dako Inc.,
Carpenteria CA). The developing reaction was stopped with the addition of 4N sulfuric
acid. Absorbance was determined at 450 nm, using a BIORAD 2550 microplate reader
and the concentrations of IL-8 were calculated with a software package (Microsoft
Excell). Levels were determined from the means of duplicate determinations for each
supernatant sample and compared with a standard curve for human recombinant IL-8.
The assay routinely detected IL-8 levels from 24 pg/ml to 6 ng/m!.
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2.7. Statistical analysis and display of data
Graphic displays of data were created using Microsoft Excell software. Statistical
analyses were performed using IMP software. Cytokine levels were expressed as the
mean±standard deviation of results from a representative from 3 identical experiments.
The data were compared using paired students t-test with significance considered to be
p<O.05.
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3. RESULTS
3.1. Dose-response study of IL-8 expression following A. a. challenge
We wanted to determine whether A.a. induces a dose-dependent increase in IL-8
expression from GECs. The following concentrations of bacterial sonicated extracts,
diluted in KSFM medium were added: 0, 0.05, 0.5, 5, 50, 500 (ug/ml). The cells were
incubated for 24 hours and the supernatants were collected, centrifuged and assayed for
IL-8 using matched-pair antibody ELISA. The results of ELISA assay for IL-8
concentration in the cell supernatants suggested a dose-dependent increase in IL-8
expression (Fig. 2.1) in the range of stimulation from 0.05-50 ug/ml A.a. protein. The IL-
8 expression induced by 0.05 ug/ml A.a. (1610±296 pg/ml) was not statistically different
compared to the basal IL-8 expression (1324±179 pg/ml). However, stimulation with
0.5ug/ml A.a resulted in a 2-fold increase in the IL-8 expression. Similarly, stimulation
with 5 and 50 ug/ml A.a. protein resulted in 3- and 7-fold increase (Fig. 2.2). As shown
in Fig.2.I, the maximal IL-8 expression was 9076±2006 pg/ml. Concentrations higher
than 50 ug/ml appeared to be cytotoxic, resulting in changes in the morphological
characteristics of the PP cell (e.g. rounding). This might explain the observed reduction in
the IL-8 expression when the cells were stimulated with concentration 500 ug/ml A.a..
The data points in Fig. 2.1 are mean values of triplicate assay determinations from one
experiment representative of 4 replicate experiments with similar results.
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Figure 2.1 Dose-response study for A.a.-induced IL-8 production by GECs
The cells were stimulated with increasing concentrations of A.a. sonicated extracts for 24
hours. The IL-8 expression was dose-dependent in the range of 0.05 to 50 ug/ml.
Stimulation with 500 ug/ml resulted in decreased IL-8 expression
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Figure 2.2 Stimulation Index (8.1.) for A.a.-induced IL-8 production by GECs
The stimulation index represents the ratio "stimulated/unstimulated" IL-8 expression.
Maximum stimulation index was observed when the cells were stimulated with 50 ug/ml
A.a. sonicates
3.2. TiDle-response study of IL-8 expression following A.a. challenge
For the kinetic study of IL-8 expression, gingival keratinocytes were stimulated
with 50ug/ml sonicated extracts of A.a. This concentration was found to induce the
maximal IL-8 expression in previous dose-response studies (see section 3.1).
Measurements of IL-8 expression in the supernatants of unstimulated or stimulated
gingival keratinocytes were conducted at the following time intervals after the beginning
of the bacterial challenge: 2, 4, 8, 12, 24 and 48 hours.
As shown in Fig. 2.3, A.a. stimulation induced IL-8 expression early as 2 h after
incubation, which increased to a peak concentration of 9927±241 pg/ml, at the end of the
48-hour experimental period, while the unstimulated cells at the same time, exhibited
lower IL-8 levels (1839±246 pg/ml). However, it should be noted that during the first 12
hours post-stimulation the levels of IL-8 expression remained under 1200 pg/ml, a value
that represents a 2 to 3-fold increase in IL-8 production compared to the basal levels (Fig.
2.4). Between 12 and 24 hours post-stimulation the IL-8 expression rapidly increased,
reaching a value of 9127±555 pg/ml, which represents a 7-fold increase compared to the
unstimulated levels (see Fig. 2.3). The data points in Fig. 2.3 are mean values of triplicate
assay determinations. This experiment is representative of 4 replicate experiments with
similar results.
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Figure 2.3 Time-response study ofA.a.-induced IL-8 expression by GEes
GEes were stimulated with 50 ug/ml A.a. sonicated extracts at time 0 and the IL-8
expression at several time periods was compared to the unstimulated controls. The data
are expressed as the mean ± S.D. of a representative experiment out of four identical
experiments. (**: p < 0.05 compared with IL-8 expressed by controls).
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Figure 2.4 Stimulation index (8.1.) of time-response study
The stimulation index represents the fold increase of stimulated IL-8 expression
compared to the unstimulated IL-8 levels for the same time period. The highest S.I. was
observed at the 24-hour supernatants.
3.3. Suppression of IL-8 expression by the specific p38 MAP kinase
inhibitor SB203580
As others and we have previously demonstrated, A.a. infection is able to
upregulate the basal gingival epithelial cell IL-8 production [5]. It has also been reported
that MAP kinases regulate upstream signaling events that control IL-8 transcription in
other epithelial cell systems [22]. We asked, therefore, whether MAP kinase activation
might be involved in A.a.-induced IL-8 production by gingival epithelial cells. In order
to evaluate the effect of p38 MAP kinase on the induction of IL-8 expression, the effect
of SB203580, a specific p38 MAP kinase inhibitor, was examined. As shown in Fig. 2.5,
gingival epithelial cell cultures were stimulated with A.a. sonicates (20 ug/ml) or rhlL-
1beta (5 ng/ml), and concentrations of IL-8 in the cell culture supernatant were measured.
After 18 h of stimulation by A.a., the extents of IL-8 augmentation compared to
the basal levels were 5.5-fold. Similarly, after 18 h of stimulation by IL-1beta (5 ng/ml),
IL-8 production was augmented by 3.5-fold (Figure 2.5). When the cells were treated
with various concentrations of SB203580, the extents of induction of IL-8 by A.a. were
significantly reduced in a dose-dependent manner. For example, at 10 uM SB203580, the
A.a.-stimulated IL-8 production was inhibited by 62% (P<O.Ol). At 30uM SB203580, the
A.a.-induced IL-8 expression was inhibited by 76%. In Figure 2.6 it can be seen that the
relation between SB203580 concentration and the percentage of IL-8 inhibition was
almost linear in the 0.1 to 30 uM range.
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Figure 2.5 Effect of p 38 MAPK inhibitor on IL-8 expression by GEes
GEes were stimulated with A.a. (20 ug/ml) or IL-1 beta (5 ng/ml), with or without
addition of p38 MAP kinase inhibitor. IL-8 levels were measured in medium harvested
after 18 h. Data are expressed as the mean ± SD. It can be noted that the p38 MAP kinase
inhibitor reduced IL-8 expression by A.a. stimulated cells in a dose-dependent manner.
(** : p ::; 0.05 compared with IL-8 concentrations in cells cultured without inhibitor).
The p38 inhibitor did not show significant cytotoxicity at concentrations 0.1 to
30uM. However, when the inhibitor was used at concentration 100uM, in preliminary
experiments, it caused morphological changes and reduced viability on the cells.
Therefore, we decided not to include the concentration 100uM in our experiments, since
the reduction in IL-8 expression could be due to decreased viability of the cells.
Interestingly, down-regulation of cellular p38 MAP kinase by pretreatment of cells with
SB20358 had no inhibitory effect on IL-1 beta-induced IL-8 production (Fig. 2.5). The
IL-8 level induced by IL-1 beta, without inhibitor, was 3.5-fold the basal (unstimulated)
expression. In the presence of 30 uM inhibitor, the level of IL-1 beta-induced IL-8 was
3.8-fold the basal level, which was slightly higher, but the difference was not statistically
significant.
P38 MAP kinase inhibitor SB 203580 suppressed the levels of IL-8 that were
induced by A.a., but not by IL-lbeta. These results indicate that multiple signaling
pathways are involved in regulating gingival epithelial cell IL-8 production, and that p38
MAP kinase may play different roles in regulating cell function in response to distinct
stimulation. Thus, the effect of p38 MAP kinase on IL-8 production appeared to be
specific for A.a. stimulation only.
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Figure 2.6 Percent inhibition of A.a.-induced IL-8 expression due to p38 MAPK
inhibitor
3.4. E. coli LPS does not induce IL-8 expression in GEes
Purified LPS from E. coli is a potent activator of cytokine responses in monocyte
models and has been used extensively in the literature as a prototype LPS for cell
stimulation [49]. To examine the cellular effects of LPS in our model, gingival epithelial
cells were exposed to purified E. coli LPS.
A dose-response study was performed with various concentrations of LPS ranging
from °to 100 ug/ml. The cells were stimulated for 24 hours with the following
concentrations of E. coli LPS: 0, 0.001, 0.01, 0.1, 1, 10, 100 ug/ml. Then, the
supernatants were harvested and assayed for IL-8 using ELISA. In Figure 2.7 we can see
that none of the progressively increasing concentrations of LPS resulted in increase of IL-
8 expression. The data presented are means from one representative experiment out of
three with similar results. There were small, non-significant differences between the
different concentrations and overall the samples were in the basal levels (300-500 pg/ml
IL-8). Peripheral blood mononuclear cells (PBMCs) were used as controls. E. coli LPS
with concentration 10 ug/ml were able to stimulate a high IL-8 response as seen in Figure
2.10. There was a lO-fold increase compared to the basal IL-8 expression by PBMCs.
That increase was consistent with previous publications [50]. These results show that
gingival epithelial cells are unresponsive to purified E. coli LPS compared with classical
LPS-responsive cells like PBMCs.
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Figure 2.7 Dose-response study of IL-8 expression by GEes challenged with E. coli
LPS
Purified LPS from E. coli did not result in significant increase of IL-8 above basal levels.
The data are from one experiment out of three experiments witl1 similar results (N.S.:
non-significant increase compared with basal IL-8 concentration ).
3.5. A.a.-induced upregulation of IL-8 expression in GEes is LPS-
independent
In order to investigate to what extent the A.a. LPS contributed to the A.a-induced
IL-8 expression, we used Polymyxin B (LPS inhibitor). The concentration of 100 ug/ml
was selected after dose-response studies (see Fig. 2.8). It can be seen that higher
concentrations of Polymyxin B (500ug/ml and 2000 ug/ml) reduce the IL-8 expression of
unstimulated GEes. This implies that they are toxic for the cells. Furthermore, 100 ug/ml
of Polymyxin B was considered adequate for LPS blockade, as shown in the PBMC
model (Figure 2.10.)
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Polymyxin B (lOOug/ml) was mixed with E. coli LPS or A.a. sonicates in order to
inactivate LPS. Then the above stimulants were added to GEes. The results of the LPS
neutralization are shown in Figure 2.9, where it can be observed that E .coli LPS failed to
upregulate the basal IL-8 expression of GECs, as we have previously seen in the dose-
response study in Fig. 2.7. It can also be seen that A.a. extracts induced significant
upregulation of IL-8 expression, which is consistent with previous studies. Interestingly,
addition of polymyxin B in the A.a. extracts caused no reduction in the A.a.-induced IL-8
expression. These results indicate that the A.a.-induced up-regulation of IL-8 was not due
to the LPS part of the extracts.
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Figure 2.8 Effect of Polymyxin B on the A.a.-induced IL-8 expression in GEes
IL-8 expression by GECs challenged with A.a. sonicates, was not affected with the
addition of Polymyxin B 50-100 ug/ml. Concentrations 500 ug/ml and higher were
cytotoxic, as can be seen from the decrease in IL-8 expression by the controls. The data
are from one experiment out of three experiments with similar results (**: p ~ 0.05
compared with IL-8 concentrations in cells cultured in medium without Polymyxin B).
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Figure 2.9 Effect of E. coli LPS and A .Q. Extracts on IL-8 expression by GEes,
with or without Polymyxin B
Purified E. coli LPS (10 ug/ml) did not result in significant increase of IL-8 above basal
levels. A.a. Extract (20 ug/ml) however stimulated high IL-8 expression, which was not
affected with the addition of 100 ug/ml Polymyxin B (which neutralized LPS). The data
are from one experiment out of three experiments with similar results (**: p ::; 0.05
compared with IL-8 concentrations in cells cultured in medium without Polymyxin B).
Peripheral Blood Mononuclear Cell (PBMC) stimulation was performed in
parallel to ensure that the endotoxic activity of A.a. LPS had been inactivated. We
measured IL-8 production by PBMC after 24 hours of incubation with commercially
prepared LPS from E. coli and with A.a. sonicates (Fig. 2.10). In each case, high levels of
IL-8 were measured. IL-8 was abolished by co-incubation with Polymyxin B. The basal
IL-8 expression by PBMCs was 100±26 ng/ml. E. coli LPS caused a 10-fold increase up
to 983± 211 ng/ml. Polymyxin B resulted to a 91.6% reduction, down to 174±5 ng/ml.
Addition of A.a. sonicates resulted to a 12-fold increase up to 1208±98 ng/ml, which was
reduced almost 98% by treatment with Polymyxin B (down to 124±11 ng/ml).
PBMCs
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Figure 2.10 Effect of E. coli LPS and A .a. Extracts on IL-8 expression by PBMCs,
with or without Polymyxin B
Peripheral Blood Mononuclear Cell (PBMC) assay was performed to ensure that the
endotoxic activity of LPS had been inactivated by Polymyxin B. Purified LPS from E.
coli and A.a.E. resulted in significant increase of IL-8 above basal levels. Addition of 100
ug/ml Polymyxin B completely inhibited the expression of IL-8, suggesting that the IL-8
expression is due to the bacterial LPS. The data are from one experiment out of three
experiments with similar results (** : p ~ 0.05 compared with IL-8 concentrations in cells
cultured in medium without Polymyxin B).
4. DISCUSSION
Characteristics of IL-8 expression induced by A. a.
Epithelial cells form a barrier that mechanically prevents bacteria fron1 invading
tissues (innate immunity). In addition they can provide signals that are essential for the
initiation and amplification of inflammatory responses. Among these signals, production
of proinflammatory cytokines is an event that participates to the cascade that leads to the
clinical and histological presentation of inflammation. The potent neutrophil
chemoattractor Interleukin-8 is one of these cytokines. IL-8 has been detected in the
gingival crevicular fluid (aCF) of adult periodontitis patients [10]. IL-8 mRNA has also
been identified in healthy and diseased periodontal tissues [12, 13]. Tonetti et al
examined gingival biopsies and reported IL-8 expression in the junctional epithelium,
adjacent to the infecting microorganisms. They suggested that the observed expression
of IL-8 in the sulcular epithelium may be an efficient way for establishment of a cell-
type-selective chemotactic gradient within the tissue, that is able to effectively direct
polymorphonuclear phagocyte migration toward the infecting bacteria [13].
A large body of information regarding cytokines, including IL-8, in response to
periodontal bacteria has been established from experiments with cultures of human
gingival fibroblasts (HGF) and human peripheral blood monocytes (PBMCs) [50, 51].
However, little is known regarding the cytokine profiles of gingival epithelial cells and
especially the cytokine levels following interaction with periopathogens. Periodontal
pathogens are routinely found in pockets of periodontally involved teeth. Among them,
Actinobacillus actinomycetemcomitans (A.a.), is a major contributor in the inflammatory
response [1, 2, 52], because of its ability to elicit pro-inflammatory cytokine release by
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host cells like keratinocytes, fibroblasts, periodontal ligament (PDL) cells, PMN's,
monocytes and lymphocytes [53, 54]. A.a. has been implicated in the pathogenesis of
periodontal conditions like Early Onset Periodontitis (EOP) and Adult Periodontitis (AP)
[1, 2, 55]. In this chapter, we analyzed the gingival epithelial cell IL-8 response elicited
by sonicated extracts of A. a. For our experiments we used an HPV-16-immortalized cell
line. This cell line was preferred over primary gingival epithelial cells for the following
reasons:
1. Isolation of primary epithelial cells from biopsies is difficult, since
fibroblast contamination can occur. Some authors recommend a reduction in Ca++
concentration in the culture medium, in order to reduce fibroblast growth.
2. There is significant variation in the cytokine profile of primary cells
depending of the inflammation status and genetic predisposition of the donor [56].
3. Primary cells cannot be maintained for more than 7 passages, whereas
immortalized cells lines can be maintained for long periods [45]. Therefore, primary
cells should be derived from the same individual, so that the results could be
comparable. This would present technical and ethical problems.
From the above, it is concluded that the use of an epithelial cell line is a convenient and
safe way to obtain reproducible results, provided that the experiments are performed with
cells from the same passage.
We, then, demonstrated that gingival epithelial cells have a constitutive IL-8
expression that ranged between 1,100 to 1300 pg/ml for 24h of bacterial stimulation.
Several studies have shown that unstimulated oral keratinocytes have detectable basal IL-
8 expression, which seems to be important for the tissue homeostasis [14]. Huang et al
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have also shown that several oral epithelial cell lines have basal IL-8 production that
ranges from 645pg/ml to 1,749pg/ml for a 24h time period [5]. The reason of these
differences is not currently known. According to McGee presence of IL-8 in non-
inflamed sulci may protect the gingiva from the bacterial challenge, by maintaining PMN
activity [57].
In Ollr study, we demonstrated that A. a. is a potent stimulator of IL-8 production
from gingival epithelial cells and that this ability was dose-related. We used the strain
ATCC 33384, which has been shown to induce optimal IL-8 expression in gingival
fibroblast cultures [51]. Stimulation with doses from 0.5ug/ml to 50ug/ml resulted in
increase of IL-8. As the concentration of A.a. protein increased above 50ug/ml, IL-8
induction was reduced. These results are in agreement with previous observations of a
dose-dependant induction of IL-8 with A.a. [5]. Huang et al showed that the highest IL-8
expression occurred at a multiplicity of infection (Mal) of 1000: 1. Beyond that bacterial
level IL-8 was reduced due to decreased viability of epithelial cells. However, when they
used non-viable bacteria they observed considerable IL-8 induction at MOls up to
5,000: 1. Others have reported that high levels of IL-8 secretion are induced by even
smaller numbers of periopathogenic bacteria. Yumoto et al have suggested that the
optimal level of secretion of IL-8 occurred at a ratio of approximately 100 to 1,000
bacteria (E. corrodens) per oral epithelial cell (KB line) [17].
We reported that the highest IL-8 induction was 7-fold compared to the control
levels, at the 24 h timepoint of continuous bacterial stimulation. Huang et al found a 7-
fold increase in the IL-8 expressed by their immortalized cell line HOK-16 in response to
A.a. challenge at the 24 h timepoint [5]. Other authors, using different bacteria as
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stimulants have reported several different increases in IL-8 production. Stimulation of
KB cells with oral viridans streptococci has caused a 5-fold increase after 20h [16].
Stimulation of KB cells with E. corrodens resulted to a 68-fold increase after 26.5h [17].
It is important to mention that the only bacterium that has been reported to down-regulate
IL-8 expression by oral keratinocytes is P. gingivalis [18]. Based on the previous findings
we suggest that the cytokine response is related to the bacterial stimulant and can vary
significantly for the different bacteria.
For our time-course studies we stimulated the cells with 50ug/ml of bacterial
sonicates, concentration that elicited the highest IL-8 expression in the dose-response
studies. We report significant upregulation of IL-8 expression as early as 2h after
continuous exposure to A.a. and maximum production of IL-8 between 12 and 24h. After
that timepoint the detectable IL-8 reached a plateau. Kinetic studies by other authors have
shown a quick IL-8 response of epithelial cells to bacterial stimulus. Huang reported a
quick IL-8 increase 6h after A.a. challenge that decreased to basal levels 12h after the
stimulus [5]. Yumoto reported significant increases of IL-8-specific mRNAs within 60 to
90 min and significant increases of IL-8 secreted protein within 4 h after the exposure of
oral epithelial cells to E. corrodens [17]. Similar results have been found regarding
interaction between bacteria and intestinal epithelial cells. Aihara et al. reported that
MKN45 cells started to express IL-8 mRNA rapidly (within 1 h) after the start of
coculture with H. pylori [58].
Rapid IL-8 expression could benefit the periodontium by recruiting PMNs to the
site of the bacterial invasion. It is known that PMNs produce high mounts of IL-8
themselves that can augment the chemotactic response. Thus, the IL-8 upregulation by
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the gingival epithelial cells is no longer necessary and the gene expression can be turned
off. We have also postulated the existence of an autocrine regulatory mechanism via IL-8
receptors CXCR-l and CXCR-2.
The bacterial challenge that we used consisted of sonicated extracts from A.a.
instead of vital bacteria. Our purpose was to examine the pathogenicity of non-vital
bacteria. It is well documented that adhering and invading epithelial cells is a major
mechanism of disease induced by A.a.. However, our data show that invasion or vitality
of A.a. is not necessary for epithelial upregulation of IL-8. This is in agreement with
recent publications by Huang et al who showed IL-8 expression induced by dead A.a.,
killed by boiling or gentamicin [5]. Sonicates of A.a. have been used in the literature for
cytokine induction in gingival fibroblasts [42]. The sonicated extracts have the advantage
that the bacterial molecules are maintained relatively unchanged whereas boiling, for
example, can denaturate proteinatious components.
In conclusion, we have demonstrated that human epithelial cells may contribute
significant levels of IL-8 in the gingival milieu in response to A.a. challenge. IL-8
derived from gingival cells, including gingival epithelial cells can cause neutrophils to
accumulate and to be activated in the site of inflammation. Thus, the capacity of the
gingival epithelial cells to produce IL-8 in response to A.a. suggests that they playa
critical role in the maintenance of the tissue microenviroment. Neutrophil mediated tissue
injury is important in the pathogenesis of periodontal diseases.
MAP Kinase and IL-8 expression
At present, little is known about the mechanisms by which A.a. induces
expression of pro-inflammatory cytokines in the cellular level. Understanding those
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mechanisms is of great interest, as it may lead to the development of novel therapeutic
approaches for the treatment of periodontitis. These approaches can focus on
modification of the cytokine expression of the host in addition to the traditional scaling
and root planing and periodontal surgery. The last decade it has been shown that the
degree of cytokine response on the bacterial challenge can affect periodontal health. Tl1e
Periodontitis Susceptibility Test (PST) has been developed by Kornman for clinical use
[59]. That test determines, after analyzing the patient's DNA, if the individual belongs to
the 30% of the population with a genetic polymorphism of the IL-1 gene. This
polymorphism results in IL-l overexpression (2- to 4- fold increase) in response to
bacterial challenge in the sulculal area. People that test PST (+) are in higher risk to
develop periodontitis [59].
In this chapter we hypothesized that IL-8 expression induced by A.a. is mediated
by MAP Kinase in the GEe model. Generally, MAP kinases regulate cell proliferation,
differentiation, and programmed death, in addition to stress and inflammatory responses.
Hence, activation of gingival epithelial cell MAP kinases by A.a. may be instrumental in
inducing periodontal inflammation, attachn1ent loss and alveolar bone loss.
MAP kinase signaling also regulates the expression of several proinflan1matory
cytokines, in other cells [60]. P38 MAPK has been implicated in the pathogenesis of
gastrointestinal inflammation due to bacteria like H. pylori and S. typhimurium [19, 46].
It is also known that p38 MAP kinase mediates IL-8 expression by bronchial epithelial
cells [22], under certain conditions.
The inhibitor of p38 MAP kinase provides an effective tool for investigating the
role of p38 MAP kinase in cellular signaling [27, 48]. SB 203580 inhibits the catalytic
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activity of p38 MAP kinase by binding to the ATP site and subsequently phosphorylating
its substrate [61]. SB 203580 inhibited p38 MAP kinase activity and significantly
reduced IL-8 expression in A.a.-stimulated cells, in a dose-dependant way, whereas it did
not affect IL-8 production in unstimulated cells. It is worth noting that, down-regulation
of cellular p38 MAP kinase by pretreatment of cells with SB20358 had no inhibitory
effect on IL-lbeta-induced IL-8 expression (Fig.2.5). That implies that there is an
intracellular pathway different of p38 MAP kinase that regulates the expression of IL-8
following exposure to IL-lbeta (Fig. 2.11). In agreement with our data, Ridley et al found
that IL-8 production by human gingival and dermal fibroblasts in response to IL-l was
independent of p38 MAP kinase activation [62]. These results demonstrate that the
activation of cellular p38 MAP kinase is indispensable for the A.a-mediated cellular
functions in gingival epithelial cells, and suggest that p38 MAP kinase may play a
different role in response to distinct stimulation.
Several publications have proven the effectiveness of SB 203580 on blocking p38
MAP kinase activity in inflammatory diseases [63]. Although it is currently not known
whether SB 203580 is capable of producing beneficial effects on periodontal tissues,
inhibiting signal cascade mediated by p38 MAP kinase, may apply in the future for
therapy of cytokine related oral conditions. Further laboratory and clinical investigations
are needed to clarify this point.
We did not examine whether other MAP kinase pathways are also involved in the
IL-8 gene expression. We believe that probably this is the case because blockade of p38
MAP kinase did not result in 100% inhibition of IL-8 expression. That nleans that there
might be parallel pathways for IL-8 regulation, which is consistent with the data that exist
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for other epithelial cell systems, like intestinal epithelial cells [19]. More studies are
needed in order to elucidate these upstream events and define the specific bacterial and
host factors that interact to activate the gingival epithelial cell signaling pathways.
Figure 2.11 P 38 MAPK regulates signal transduction pathway for IL-8 expression
A.a stimulates the expression of IL-8 gene with final result the excretion of IL-8 in the
extracellular environment. P38 MAP kinase mediates the events that will lead to DNA
transcription.
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Role of LPS in A.a.-induced IL-8 expression in GEes
Lipopolysaccharide (LPS) is a basic component of the Gram(-) bacterial outer
membrane and is therefore constantly presented to the oral mucosa surfaces. How do
tissues react to this constant exposure? We hypothesized that the A.a.-induced
upregulation of IL-8 by GEes was due to the LPS content of this bacterium. We
demonstrated that gingival epithelial cells released IL-8 after challenge with A. a.
sonicates which was both dose- and time-dependent. The effect of A.a. sonicates was not
inhibited by Polymyxin B neutralization of LPS. This suggests that LPS was not the
causative factor for the epithelial stimulation (see Fig. 2.12). We also demonstrated that
gingival epithelial cells were unresponsive to commercially purified E. coli LPS. Similar
findings have been reported with other epithelial cell lines, like bronchial and
uroepithelial cells [31, 39].
When peripheral blood mononuclear cells (PBMCs) were exposed to A.a.
sonicates and E. coli LPS, high levels of IL-8 were detected in the cell supernatant. In
contrast with the gingival epithelial cell line, this effect was inhibited by Polymyxin B. It
was therefore demonstrated that LPS derived from A.a. and E. coli was the major factor
that upregulated IL-8 expression in PBMCs. The PBMC model, except the information
about LPS stimulation, validated the effectiveness of LPS blockade by Polymyxin B.
Although several investigators have exposed PBMCs to A.a., there are only two
publications that have examined the IL-8 response to A.a. LPS:
• Agarwal et al were the first to show IL-8 increase after exposure of
monocytes to A.a. LPS [54].
76
• Yamaguchi et aI, one year later, demonstrated increase of IL-8 mRNA in
response to A.a. LPS [33].
Finally, in another paper Jiang et al (1996) used whole A.a. bacteria instead of
LPS for stimulation of monocytes [50]. They demonstrated a 6-fold increase of IL-8
excretion. However, they did not prove that this increase was due to the LPS component
of A.a.. Therefore, only in the first of these publications (Agarwal et al., 1995) has been
shown direct cause-effect relation between A.a. LPS and IL-8 protein production. Our
results provide additional evidence that A.a. LPS are responsible for the IL-8
upregulation by human PBMCs.
In studies of cytokine inductive properties of stimulatory agents, it is important to
control for unstimulated production of cytokines and lack of periodontal inflammation
[8]. Therefore, the PBMC donor, in our study, was a systemically and periodontally
healthy young adult. Periodontal health was defined as lack of pockets with probing
depth more than 3mm and no bleeding on probing (BOP) in any site. There are several
lines of evidence showing that PBMCs from periodontally diseased individuals exhibit
altered reactivity to plaque bacteria and this is exactly what we wanted to avoid. A study
of PBMCs from periodontal patients demonstrated that unstimulated cells and cells
stimulated with LPS derived from A.a. produced more IL-lbeta than did similarly
stimulated cells from healthy controls [64]. Others have shown that upon stimulation with
LPS, monocytes from periodontitis patients release more IL-l beta and PGE2 than
monocytes from gingivitis subjects [65].
Our study suggests that epithelial cells differ from cells in the systemic
compartment, in that they are extremely poor responders to direct stimulation by LPS,
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and that the pathogens overcome this unresponsiveness and trigger similar but LPS-
independent cytokine responses. These results also emphasize the difference in LPS
response strategy between epithelial cells in the oral lining and the macrophages in the
systemic compartment. A number of candidate cellular components and exoproducts
from A.a. and other periopathogenic bacteria have been examined for their ability to elicit
cytokine expression. These include the following: polysaccharides, surface-associated
material (SAM), lipid A-associated proteins (LAP), porins, fibriae and cell wall polymers
(CWP). A more detailed review has been presented in the introduction section and the
findings have been summarized in table 2.1.We do not know the reason of the epithelial
unresponsiveness to LPS. Future studies can examine whether normal gingival epithelial
cells lack receptors CD14, which could explain this phenomenon. This could be done
with immunohistochemical staining of gingival biopsies or with ELISA using
homogenates from gingival epithelium.
Although our studies show that gingival epithelial cells, in vitro, respond to A.a.
sonicates in an LPS-independent manner, tl1ey do not imply that LPS is inactive in the
mucosal compartment or that Gram-negative bacteria elicit totally LPS-independent
inflammatory responses at these sites. We do not know if human epithelial cells, in vivo,
respond similarly in LPS stimulation. If they do, then we can assume that LPS is likely
to interact with non-epithelial cells in the connective tissue compartment of the
periodontium, since the stimulatory ability of LPS has been already demonstrated. Once
LPS reaches CD14-positive or other responsive cells in the subepithelial compartment, a
release of pro-inflammatory mediators may be induced with subsequent inflammatory
response with clinical and histological signs.
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Figure 2.12 A.a.-induced IL-8 expression in GEes is LPS-independent
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CHAPTER 3
Characterization ofA. actinomycetemcomitans-induced
interleukin-l expression by human gingival epithelial
cells. Implications in interleukin-8 expression
ABSTRACT
Gingival epithelial cells are the first cells of the host that encounter the bacterial
challenge and therefore their role in the initiation of the immune response is critical. We
have already shown than Actinobacillus actinomycetemcomitans (A.a) can induce IL-8 in
human gingival epithelial cells (GEC). In this chapter, we hypothesized that A.a. is also
able to induce IL-l expression in GEes in vitro. IL-l is a major cytokine produced in
inflamed periodontal tissues. Furthermore, IL-l has been implicated in the regulation of
bacterial-induced IL-8 in endothelial and respiratory epithelial cells. We also
hypothesized that exogenous IL-l, when added to a GEC culture can upregulate IL-8
expression. We finally hypothesized that the IL-8 expression that is induced by A.a. is
mediated by endogenous IL-l in an autocrine fashion.
Sonicated extracts of A.a. were added to GEe cultures, supernatants were
collected at varying time intervals and analyzed for IL-l expression with ELISA.
Similarly rhIL-lalpha and rhIL-lbeta were added to the GEe cultures and the
supernatants were analyzed for IL-8 expression. Finally, inhibitors of IL-l were added to
the cultures and then the cells were exposed to A.a. or rhIL-lalpha and/or rhIL-lbeta and
the IL-8 expression was determined.
Addition of A.a. extracts caused a significant increase for both IL-lalpha and IL-
Ibeta. Increase of IL-lalpha expression was induced as early as 2h post-stimulus. Within
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l2h, the IL-lalpha expression corresponded to 6-fold increase compared to the
unstimulated levels. IL-l beta, that was initially below detectable levels, increased
significantly after l2h of stimulation with A.a. Overall, IL-lalpha levels induced by A.a.
were 5 to 20 times higher than IL-l beta, depending the time of sampling. After
comparing the time-response curves of the two cytokines, we described an "early
stimulatory effect" regarding the induction of IL-1alpha by GEC. When the cells were
challenged with either IL-lalpha or IL-l beta, the dose with the highest IL-8 stimulation
was lOng/ml for both of these cytokines. Significant upregulation of IL-8 expression was
detected as early as 2h after exposure to IL-l, reached a maximum after 24 hours from
the beginning of the experiment and then declined. Incubation of GECs with IL-l
inhibitors blocked the production of IL-8 induced by rhIL-l. This validated the
effectiveness of our inhibitors. However, IL-l inhibitors failed to reduce the A.a.-induced
IL-8 expression by GECs after 12 and 18 hours of stimulation.
In conclusion, A.a. is capable of amplifying the local immune response and
promoting periodontal tissue inflammation by stimulating GEe to secrete IL-lalpha and
IL-l beta. We showed that gingival epithelial cells are capable of upregulating IL-8
expression in response to exogenous IL-l challenge and thus may facilitate the
recruitment of leukocytes. However, there was no evidence that the A.a.-induced
expression of IL-8, is mediated by endogenous IL-l in an autocrine fashion. Rather, it
appears that A.a. stimulates epithelium either by a direct signaling mechanism or by
induction of a different host-derived proinflammatory cytokine. A third possibility is also
discused, this one of an intracrine IL-l-dependent pathway. Further experiments are
needed in order to elucidate these intracellular functions.
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The involvement of IL-I in the intercellular signaling can have clinical
implications. Recent data have associated periodontitis-prone individuals with IL-I
hyper-secretory genotypes. Therefore, inhibitors of IL-I may be useful in suppressing
inflammation due to IL-I alpha and IL-Ibeta and reducing the detrimental effects that
their hyper-secretion exerts to the periodontium.
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1. INTRODUCTION
IL-l expression in GEes
Interleukin-I (IL-I) is a hormone-like cytokine that plays a central role in the
regulation of immunologic and inflammatory reactions. There are two functionally
almost equivalent forms of IL-I, IL-Ialpha (17 kDa, 159 amino acids) and IL-lbeta (17
kDa, 153 amino acids) that are encoded by two different genes. At the protein level IL-
lalpha and IL-Ibeta display approximately 27 percent homology. On the other hand the
three-dimensional structure of the two IL-I forms is almost identical and both forms bind
to the same receptor [1]. Primary producers in the periodontal lesion are
monocytes/macrophages, dendritic cells, Langerhans cells, B lymphocytes, endothelial
cells, neutrophils, fibroblasts and epithelial cells. Epidermal keratinocytes have been
shown to have receptors for IL-l and therefore are responsive to IL-l treatment [2]. The
main biological activity of IL-I is the stimulation of T helper cells, which are induced to
secrete IL-2, IL-4, IL-6, IFN-gamma and CSF [1]. IL-I acts directly on B-cells,
promoting their proliferation and the synthesis of immunoglobulins. IL-I stimulates the
proliferation and activation of NK-cells and fibroblasts. It also induces ICAM-l, E-
selectin and VCAM-I on endothelial cells, enabling PMNs, monocytes and lymphocytes
to migrate into the tissues [3]. Biological effects of IL-I that are directly related to
periodontal attachment are activation of collagenase, bone resorption and induction of
other mediators including PGE2, PF4 (platelet factor-4), CSF (colony stimulating factors),
IL-6 and IL-8 .
Interleukin-I was the first cytokine shown to be produced by keratinocytes [4]. It
is IL-l alpha that is responsible for the biological activity of IL-I in skin keratinocytes as
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assessed by a thymocyte proliferation assay [5]. Formanek et al examined the cytokine
expression and corresponding receptor pattern of unstimulated human oral mucosa-
derived keratinocytes [6]. IL-1alpha and IL-1alpha receptor antagonist, were detectable at
the protein and mRNA level. Johnson et al reported that oral keratinocytes, in culture,
express both IL-1alpha and IL-1beta [7]. The levels of IL-1 alpha from the lysed cells,
however, were 20 times higher than the levels of IL-1beta, after 24 in culture (120
pg/104cells versus 6pg/104 cells respectively). Only IL-1alpha could be detected in the
culture supernatant after 24 hours (2-3pg /104 cells)[7]. Li et aI, (1996) compared the
cytokine profile of oral keratinocytes (OK) with that of skin keratinocytes (SK)[8].
Unstimulated OK and SK produced IL-1 alpha constitutively. The IL-1alpha produced by
OK (43 pg/ml/106cells/24h) was doubled after stimulation with TNF alpha. Overall there
was no significant difference in the IL-1 alpha production between OK and SK.
Yamamoto reported that gingival keratinocytes, in vitro, excrete 30-40 pg/105cells/ml IL-
1beta over a 3-day period [9]. Keratinocytes obtained from inflamed gingiva excreted
more IL-1beta compared to keratinocytes from non-inflamed sites and exposure to LPS
(10ug/ml) increased further the IL-1 beta production.
Several studies have shown the presence of IL-1 in inflamed gingival tissues.
Honig et al found IL-1beta present in all tissue extracts from adult periodontitis patients,
whereas no IL-1 was found in 11ealthy tissues [10]. Charon et ale demonstrated that IL-1
is present in a greater extent in gingival fluid (GCF) from inflamed sites [11]. Masada et
al detected IL-1 alpha and IL-1 beta in the GCF of all 15 patients with untreated
periodontitis that they examined [12]. Both forms of IL-1mRNA were detected in
gingival tissue samples. Jandinski et al observed that IL-1 beta positive cells were
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increased by almost 3-fold in periodontally diseased tissue when compared to normal
tissue [13]. Stashenko reported that IL-lbeta is the predominant form present in
periodontal tissues [14]. Disease-active sites had higher IL-l beta than inactive and
healthy sites and IL-lbeta levels were related to attachment loss. Matsuki et al reported
that IL-l activity in gingival crevicular fluid (GCF) from inflamed gingiva was higher
than that from healthy gingiva and decreased after periodontal therapy [15]. They also
found that IL-l alpha was the predominant form of IL-l in GCF. Similarly, Reinhardt et
al showed that IL-lalpha was the predominant form of IL-l in GCF, which was 5-fold
higher than IL-lbeta [16]. They also showed that presel1ce of A.a. in a site caused a 3-
fold increase in both IL-lalpha and IL-lbeta in GCF.
The results of the above studies suggest that IL-l is locally produced in the
gingival tissue and that raises the question of the cellular origin of IL-l in the periodontal
microenvironment. Expression of IL-l has been demonstrated with IRC both in gingival
epithelium [17] and gingival connective tissue [15, 18]. When IL-lbeta is expressed in
inflamed gingiva it usually reflects the density of infiltrating macrophages [19].
We hypothesized that A.a. can induce both IL-lalpha and IL-lbeta in human
gingival epithelial cells in culture. We exposed GECs to sonicated extracts of A.a. for
several time periods and then assayed the cell medium for IL-l alpha and IL-lbeta using
ELISA. Our results demonstrated that A.a. induced both IL-lalpha and IL-lbeta in
human GECs in culture. The production of those cytokines was time-dependent. IL-
lalpha was expressed as early as 2h post-stimulus. This was described as an "early
stimulatory effect" and may have implications in the secondary expression of IL-8. Our
next objective in this chapter was to show that IL-l can induce IL-8 in GEes, in vitro.
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IL-l-induced IL-8 in GEes
It has been shown that stimulation with IL-1alpha and TNF-alpha can increase IL-
8 production by primary human oral keratinocytes [20]. Stimulation for 24 h with 100-
1,000 Vlml of IL-alpha also induced IL-8 production by oral keratinocytes [20]. Bickel
et al studied the influence of IL-1 alpha on chemokine expression of 2 human oral
keratinocyte cell lines: SCC-25 (squamous cell Ca) and HEPM (human embryonatal
palatal mucosa cells) [21]. IL-1 stimulation resulted in an increase of mRNAs encoding
interleukin-8 (IL-8), monocyte chenl0attractant protein-1 (MCP-1), and ORO gamma.
IL-8 mRNA was expressed as early as 1 hour after stimulation and reached a first peak
after 4 hours.
We hypothesized that rh IL-1alpha and rh IL-1beta can induce IL-8 expression in
GECs. We performed dose-response and time response studies by adding different
concentrations of recombinant human IL-1 alpha and IL-1beta in cultures of GECs and
then assaying the supernatants for IL-8 using ELISA.
Our results indicate that oral epithelial cells are capable of upregulating IL-8
expression in response to exogenous IL-1 challenge. Since IL-1 is abundant in the
periodontal environment during inflammation, this provides an indirect mechanism for
IL-8 upregulation and thus may facilitate the recruitment of leukocytes as a host defense
mechanism.
Effect of IL-l inhibitors on bacterial-induced IL-8
We have shown that GECs secrete IL-1 in response to A.a. and that rh IL-1 can
induce IL-8 in the same cell model. We then studied whether A.a.-induced IL-1 is
involved in the regulation of IL-8 expression in an autocrine manner. IL-1-dependent
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autocrine pathways for IL-8 regulation have been described in endothelial and respiratory
epithelial cells. Kaplanski et aI, found that both IL-8 and IL-6 production by R. conorii-
infected human umbilical vein endothelial cells (HUVEC) was mediated, in a large part,
by a cell-associated form of IL-lalpha [22]. Production of IL-8 was suppressed by 80%
by the addition of IL-IRA and by 60% by anti-IL-lalpha antibodies. IL-lalpha has also
been reported by Patel et al. to be an autocrine regulator of IL-8 production by a
pulmonary epithelial cell line infected with respiratory syncytial virus (RSV) [23].
Incubation with neutralizing antibodies against IL-l alpha and IL-lbeta showed that IL-
lalpha was the predominant soluble mediator that enhanced the mRNA expression and
synthesis of IL-8. Porat et al examined whether LPS-induced IL-8 production by human
peripheral blood mononuclear cells (PBMCs) was due to endogenous IL-l [24]. The
addition of saturating concentrations of IL-IRA reduced the IL-lbeta-, LPS-, and B.
burgdorferi-induced IL-8 synthesis by 85, 50, and 40%, respectively, indicating that IL-l
is involved in the regulation of IL-8 in PBMCs in an autocrine manner.
Other authors have shown that IL-8 upregulation is independent of endogenous
IL-l. Bums et ale found that activation of endothelium by B. burgdorferi, is not mediated
through an autocrine action of secreted IL-l, since IL-l RA had with no effect on the
bacterial induced IL-8 [25]. They suggested that B. burgdorferi must stimulate
endothelium either directly, or by induction of a novel host-derived proinflammatory
cytokine.
Chen et al examined the effects of IL-l alpha, IL-lRA or anti-IL-l neutralizing
antibody upon expression of proinflammatory cytokines in oral squamous Ca (SCC) cell
lines [26]. They found that IL-RA or anti-IL-l neutralizing antibody could completely
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inhibit the IL-lalpha-inducible increase in IL-8 expression. Unfortunately, nothing has
been published regarding periodontal pathogens and their interactions with gingival
epithelial cells. Since our previous studies have shown that A.a.-infected epithelial cells
express both IL-l alpha and IL-lbeta, we hypothesized that endogenous IL-l induced by
A.a. mediates the expression of IL-8 in GECs.
We used anti-IL-l neutralizing antibodies and rhIL-lRA to neutralize the
endogenous IL-l expressed by GEes after A.a. infection. The effectiveness of those
inhibitors was tested by examining whether they could reduce the IL-l-induced IL-8.
First the IL-l inhibitors were added to the cultures and 30 min later the A.a. stimulus was
introduced. The culture medium was collected at various timepoints and assayed for IL-8.
Our results showed that blockade of secreted IL-l did not result in significant
change in the expression of IL-8 in A.a.-stimulated GECs. Although our findings do not
support our original hypothesis for autocrine regulation, we cannot rule out the role of
IL-l in the regulation of IL-8. The possibility of an intracrine mechanism, that involves
IL-l expression is still to be tested for possible involvement in the expression of IL-8.
The involvement of IL-l in the intercellular signaling can have clinical implications.
Recent data have associated periodontitis-prone individuals with IL-l hyper-secretory
genotypes [27]. Therefore, inhibitors of IL-l may be useful in suppressing inflammation
due to IL-l alpha and IL-l beta and reducing the detrimental effects that their hyper-
secretion exerts to the periodontium.
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Figure 3.1 Hypothesized IL-l autocrine regulation ofIL-8 expression in GEes
We hypothesized that A.a. induces IL-8 expression in GEes via IL-l mediation. In this
chapter we test our hypothesis by utilizing IL-l -inhibitors for neutralization of
endogenous IL-l that is induced by A.a.
2. METHODS
2.1. Culture of GECs
For our experiments we used human gingival epithelial cells immortalized with
the Human Papilloma Virus type 16, the E6/E7 gene [28]. This cell line-named PP- was
kindly provided by Dr. Oda, Department of Oral Biology, University of Washington,
Seattle. The cells were kept frozen in liquid N2. Before every experiment the cells were
thawed, plated into tissue culture flask (Falcon, Franklin Lakes NJ) and fed every 48
hours. The medium used was Keratinocyte Serum-Free Medium (KSFM, Gibco). Cell
cultures were maintained at 37°C and 5% CO2• The cells were grown up to the required
number (3-4 x 106 cells) into 75 cm2 tissue culture flasks (Costar). They were trypsinized
using 0.025% bovine trypsin in 0.01 % EDTA (Clonetics, Walkersville, MD). The cells
were then plated into 12-well tissue cultllre plates (Costar, Cambridge, MA), 2 x 105
cells, in 1 ml medium per well, and were incubated for 4-6 hours in order to adhere and
reach confluence. There were triplicate wells for each condition. For antibody studies
triplicate cultures of GECs were plated at 96-well plates at a density of 4x104 cells per
well. The cells were left to adhere for 4-6 hours. Then, 100ul of KSF medium that
contained the antibodies was added to the wells and 30 minutes later the stimulus was
introduced (bacterial extract or recombinant cytokine or plain medium) to a final volume
of 200ul. After incubation for various time periods, the supernatants were aspirated,
centrifuged, and stored at -70°C until they were assayed for cytokine.
2.2. Bacterial challenge
Actinobacillus actinomycetemcomitans strains (ATCC 33384), were kindly
provided by Dr. J. Slots, University of Southern California School of Dentistry, Los
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Angeles CA, USA. The bacteria were grown for two 3-4 day periods and subcultured
after each growth period to ensure strain purity. Cells were harvested by washing and
suspension in 3 ml sterile phosphate buffered saline (PBS), followed by sonication to
extract soluble bacterial componel1ts. Briefly, cells suspended in PBS were subjected to
10 repetitions of sonication at 5-minute intervals at a 10% duty cycle. The cell free
supernatant was then collected by centrifugation at 8000 rpm for 30 minutes at 4° C and
dialyzed with sterile PBS at 4° C. Bacterial protein concentration was determined by
Bradford protein assay (Bio-Rad, Richmond CA). The extracts were aliquoted and stored
at -70°C. Sonicated extracts were used as bacterial challenge in various concentrations in
the culture medium.
2.2.1. A.a.-induced IL-l expression in GEes
In order to demonstrate that A.a.E. induces IL-l in GECs the cells were stimulated
with 50 ug/nl1 A.a.E. and the supernatants and lysates were assayed at various time-points
for IL-lalpha and IL-lbeta (ELISA). The flow diagram below describes the procedure:
GECs (PP cells)
J,
96-well Culture Plates
J,
± A.a. Extracts
J, 0-48h / 37°C, 5%C02
Supernatant/Lysates
J,
IL-lalpha / IL-lbeta ELISA
2.3. Antibodies and proteins
Recombinant human Interleukin-lalpha (rhIL-lalpha) and Interleukin-lbeta
(rhIL-l beta) was supplied by Endogen (ENDOGEN Inc. Cambridge MA). Goat
polyclonal neutralizing antibodies against rhIL-l alpha and rhIL-lbeta were purchased
97
from R&D Systems (Minneapolis, Minn.). Recombinant human IL-l receptor antagonist
(rhIL-lRA) was obtained from R&D Systems, as well. Purified goat non-immune IgG (N
IgG), obtained from Signla (Sigma Chemical Co., St. Louis, Mo.), was used as control
antibody.
2.4. Neutralization of exogenous IL-l
In order to confirm the neutralizing activities of the antibodies and IL-lRA, they
were mixed with the respective recombinant cytokines and IL-8 expression from GECs
stimulated with the above mixture was determined. The cytokine concentration was 5
ng/ml for both rhIL-lalpha and rhIL-lbeta. The NDso for anti-IL-lalpha was 2 ug/ml and
for IL-lbeta 10 ug/ml, as determined by the manufacturer. The final concentration of
antibodies that were used against rhIL-lalpha (2-10 ug/ml) and against rhIL-lbeta (10-50
ug/ml) was determined based on the NDso• As control antibodies, similar concentration of
goat IgG was used. The final concentration of rhIL-lRA was 800 ng/ml. The flow
diagram below describes the procedure:
GECs
1,
96-Well Culture Plates
1,
Pre-incubate GECs with
@IL-lalpha or @IL-lbeta or N IgG or IL-lRA
1,
Add
rhIL-lalpha(5ng/ml) or rhIL-lbeta(5ng/ml) or Media
1, 0-18h, 37°C, 5%C02
SupematantslLysates
1,
IL-8 ELISA
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2.5. Neutralization of A.a.-induced endogenous IL-l
Based on the quantities of endogenous IL-l alpha and IL-lbeta detected in
supernatants of PP cells (see section 3.1), neutralizing antibodies against the respective
cytokines or rhIL-lRA were added to the medium in more than 10-fold excess of the
recommended concentrations. Those concentrations were based on the NDso of the
antibodies and IL-lRA 1. The inhibitors were first added to the cultures and 30 minutes
later the bacterial extracts were introduced. The final concentration of antibodies against
endogenous IL-l alpha and IL-lbeta was 10 ug/ml. As control antibodies, similar
concentration of goat IgG was used. The final concentration of rhIL-lRA was 200 ng/ml.
The flow diagram below describes the procedure:
GECs
~
96-Well Culture Plates
~
Pre-incubate with @IL-lalpha or @IL-lbeta or NIgG or IL-lRA
~
A.a.E / Media
~ 0-18h, 37°C, 5%C02
Supernatants /Lysates
~
IL-8 ELISA
1 Neutralization Doseso (NDso) for an antibody/inhibitor is defined as the required
concentration to yield one-half maximal inhibition of the cytokine activity on a
responsive cell line, when that cytokine is present at a concentration high enough to elicit
a maximum response. The NDso for anti-IL-lalpha was 0.008-0.02 ug/ml in the presence
of 50 pg/ml of rh IL-lalpha. The NDso for anti-IL-lbeta was 0.05-0.1 ug/ml in the
presence of 50 pg/ml of rhIL-lbeta. The NDso for rh IL-lRA was 7-10 ng/ml in the
presence of 50 pg/ml of IL-lalpha (according to R&D systems, product specifications).
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2.6. Measurement of IL-lalpha and IL-lbeta
Quantification of IL-l was accomplished using a matched pair enzyme-linked
immunoassay (ELISA) (Endogen Inc. Cambridge MA). Briefly, 96 well assay plates
were treated for 12 hours with 8.0 ug/ml mouse anti-human IL-lalpha or 2.0 ug/ml
mouse anti-human IL-lbeta monoclonal coating antibody (Endogen Inc. Cambridge
MA). Then, blocking bllffer was added for one hour, followed by I-hour incubation with
25 ul aliquots of gingival keratinocyte culture supernatant. Assay plates were then
incubated with biotinylated mouse anti-human IL-l monoclonal detecting antibody at 0.8
ug/ml (anti-IL-lalpha) and 0.5 ug/ml (antiIL-lbeta) and linked to horseradish peroxidase-
conjugated streptavidin at a dilution 1/8,000. (Zymed Laboratories Inc., San Francisco,
CA). Assay plates were then incubated with tetramethylbenzidine (TMB) substrate (Dako
Inc., Carpenteria CA). The developing reaction was stopped with the addition of 2N
sulfuric acid. Absorbance was determined at 450 nm, using a BIORAD 2550 microplate
reader and the concentrations of IL-lalpha and IL-lbeta were calculated with a software
package (Microsoft Excell). Levels were determined from the means of duplicate
determinations for each supernatant sample and compared with a standard curve for
human recombinant IL-lalpha and IL-lbeta. The assay routinely detected IL-lalpha and
IL-lbeta levels from 7.8 pg/ml to 500 pg/ml.
2.7. Measurement of IL-8
Quantification of IL-8 was accomplished using a matched pair enzyme-linked
immunoassay (ELISA) (Endogen Inc. Cambridge MA) as described above for IL-Ialpha
and IL-lbeta. The concentration of mouse anti-human IL-8 monoclonal coating antibody
(Endogen Inc. Cambridge MA) was 2 ug/ml and that of biotinylated mouse anti-human
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IL-8 monoclonal was 0.1 g/ml. The assay routinely detected IL-8 levels from 24 pg/ml to
6 ng/ml.
2.8. Statistical analysis
Cytokine levels were expressed as the mean±standard deviation of results from a
representative from 3 identical experiments. Statistical analysis of the data was performed
using paired students t-test with significance considered to be p<0.05.
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3. RESULTS
3.1. A.a. induces IL-l expression in GEes in vitro
In this section we are going to demonstrate that infection with A.a. induced
significant expression of both IL-lalpha and IL-lbeta by GECs. The kinetics of those
cytokines are going to be presented in detail and they are going to be compared with the
kinetics of IL-8 expression induced by A.a. in an attempt to detect associations.
3.1.1. A.a. induces IL-lalpha expression in gingival epithelial cells (GEes)
In order to determine the kinetics of the A.a.-induced-IL-lalpha expression by
GECs, cell monolayers were exposed to A.a. sonicated extracts and the cytokine
expression was compared to the unexposed controls. Expression of IL-lalpha was
determined for each time point by removing the medium from the specific wells and
assaying using ELISA. The results shown in Figure 3.2 are from a representative
experiment out of four with similar results. The data-points represent mean values from
triplicate wells. It is clearly shown that a significant increase in the IL-lalpha expression
was observed as early as 2 hours after the bacterial challenge. At that time point, the basal
IL-lalpha expression was 30±13pg/ml, whereas the A.a.-stimulated IL-lalpha expression
was 137±12pg/ml, which was over 4.5 times higher. Between the 4- and 12-hour time-
point, there was a linear increase in IL-l alpha concentration in the supernatant, reaching
a value of 199±lpg/ml, which corresponds to a 5.7-fold stimulation compared to
unstimulated controls. As it can be seen in Figure 3.3, the highest stimulation index (5.7)
was observed at the I2-hour time point. Between 12 and 48 hours, IL-Ialpha increased
gradually and reached the maximum value of 291±11pg/ml. The stimulation index,
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however, decreased at 24 hours to a value of 2.2 and remained in that level for the rest of
the experimental period.
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Figure 3.2 A.a. induces IL-lalpha expression in GEes
Gingival epithelial cells were stimulated with 50 ug/ml A.a. sonicated extracts. IL-lalpha
was compared to unstimulated controls (dotted line). Rapid increase of IL-lapha by the
stimulated cells was observed during the first 12 hours. The basal IL-lalpha expression
showed a steady increase over time. The data are expressed as the mean ± S.D. of a
representative experiment out of four identical experiments. (**: p < 0.05 compared
with IL-lalpha expressed by controls).
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Figure 3.3 Stimulation Index (SI) of IL-lalpha expression induced by A.a.
The stimulation index represents the fold increase in IL-1alpha by gingival epithelial
cells stimulated with A.a. sonicates compared to the unstimulated controls. The data are
expressed as the mean ± S.D. of a representative experiment out of four identical
experiments.
3.1.2. Comparison of the kinetics of IL-lalpha with the kinetics of IL-8 induced by
A.a.
In chapter 2 we showed that the level of IL-8 expression induced by A.a. sonicates
was quite high, reaching 10,000 pg/ml, after 24 hours. The IL-1alpha levels, however,
that were detected in the same supernatants and for the same time period were 40 times
lower. The time-course study of both cytokines is presented in Figure 3.4. It is important
to note that the increase in IL-1alpha production occurred as early as 2 hours post-
stimulation and peaked at 12 hours. The peak IL-8 expression occurred at 24 hours and
the levels of this cytokine remained high until the end of the experiment. In Fig.3.4, it can
be seen that the peak of the IL-8 response to the bacterial challenge lagged significantly
compared to the IL-1alpha response, which can be considered "immediate". Even though,
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in absolute concentrations, IL-8 was overwhelmingly the major cytokine detected, during
the first 12 hours the relative increase in IL-lalpha expression by the cells is higher than
that of IL-8. At the 24 and 48-hour time-points, things were reversed, with a delayed
increase in IL-8 expression and decrease in IL-l alpha.
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Figure 3.4 Comparison between SI ofIL-lalpha and IL-8 induced by A.a.
The Stimulation Index is presented here. Notice the delay in peak IL-8 response
(interrupted line) compared to the IL-lalpha response (continuous line).
3.1.3. A.a. induces Interleukin-lbeta expression in gingival epithelial cells.
The kinetic study of IL-1 beta was performed by removing and assaying the
supernatants for IL-1beta at, the following timepoints: 2h, 4h, 8h, 12h, 24h and 48h. The
results presented in Figure 3.5 are from one experiment representative of four
experiments with identical results. There are two curves representing a) the IL-1beta
expression by the gingival keratinocytes stimulated with sonicates from A.a. with protein
concentration 50 ug/ml and b) the IL-1 beta expression by unstimulated cells. It is shown
that there were no detectable IL-lbeta levels in the supernatants from the unstimulated
cells. The sensitivity of our assay was 7 pg/ml IL-lbeta. Concerning the stimulated cells,
it can be noted that until the 8-hour time point there were no detectable levels of IL-
1beta. IL-lbeta expression was detected at 12 and 24 hours as seen in Figure 3.5. The
cytokine expression increased over time and reached the maximum level (29 pg/ml) at 48
hours after stimulation
3.1.4. Comparison of the kinetics ofIL-lbeta with the kinetics ofIL-8 induced by
A.a.
The relative cytokine expression was compared for IL-lbeta and IL-8 (Figure 3.6)
Although IL-8 production was 250 times higher that IL-1beta there are some interesting
observations regarding the relative production of these two cytokines over time.
• They both had a limited expression during the first 12 hours. This comes in contrast
with the IL-1alpha expression, which reached high levels as early as 2h after the
beginning of A.a. stimulation.
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• Both cytokines increased gradually to their maximum expression at the 48-hour time
point. However, the main increase in IL-8 expression (from 7% to 97%) occurred
between 12h and 24h, whereas the main increase in IL-1beta (25% to 100%) took
place between 12 and 48 hours and was more gradual.
• It is concluded that the kinetics of these two cytokines present several similarities as
well as differences. Compared to the kinetics of IL-1alpha they can be characterized
as "delayed response cytokines" despite the fact that significant stimulation of IL-8
occurred as soon as 2h the main difference between IL-8 and IL-1beta was that IL-8
reached the maximum expression at 24h, whereas IL-1beta reached the maximum one
day later.
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Figure 3.5 A.a. induced IL-lbeta expression in GEes
Gingival keratinocytes were stimulated with 50 ug/ml A.a. sonicates. The basal IL-lbeta
expression was below detectable levels (dotted line). The data are expressed as the mean
± S.D. of a representative experiment out of four identical experiments. (**: p < 0.01
compared with IL-8 expressed by controls).
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Figure 3.6 Comparison between kinetics of IL-lbeta and kinetics of IL-8
Both cytokines were produced by A.a.-stimulated gingival epithelial cells. Here, they are
presented as cytokine levels above the basal expression. The data are expressed as the
mean ± S.D. of a representative experiment out of four identical experiments.
3.1.5. Comparison of the kinetics of IL-lalpha with the kinetics of IL-lbeta induced
by A.a.
In Figure 3.7 the right axis corresponds to IL-lbeta expression whereas the left
corresponds to IL-lalpha. IL-lalpha production was approximately 5 times higher that
IL-lbeta. The following observations were made regarding the relative production of
these two cytokines over time. During the first 12 hours IL-lalpha reached a maximum
but this did not happen with IL-lbeta until 36h later. IL-lalpha was detected as soon as
2h, whereas IL-lbeta was first detected 10h later, at 12h-timepoint. After that moment
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IL-lbeta continued to increase, but IL-1 alpha actually reached a plateau. It is concluded
that the kinetics of these two cytokines are significantly different.
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Figure 3.7 Kinetics of IL-lalpha and IL-lbeta induced by A.a.
Levels above the basal expression are presented here. The data are expressed as the mean
± S.D. of a representative experiment out of four identical experiments.
3.2. IL-lalpha induces IL-8 expression
In this section of the results we demonstrate that IL-1alpha induced significant
expression of IL-S in GECs. The dose-response and kinetic stydies are presented and they
are compared with the kinetics of IL-S expression induced by A.a. in an attempt to detect
associations.
3.2.1. IL-lalpha induces IL-8 in a dose-dependent way
Our goal was to determine how increasing concentrations of rhIL-lalpha would
affect the IL-S expression. In addition, we wanted to determine what concentration of IL-
1alpha would elicit the highest IL-S response by GECs. Therefore, monolayers of cells
were incubated for 24 hours in the presence of 0, 0.3, 1, 3, and 10 ng/ml rhlL-lalpha
Then, the supernatants were collected and assayed for IL-S using ELISA.
Our results demonstrated a dose-dependent relation between IL-1alpha and IL-S.
The findings can be seen in figure 3.8. The data presented in that figure are from one
representative experiment out of three consecutive experiments with similar results. It can
be seen that with increasing concentrations of IL-1 alpha, GECs expressed increasing
levels of IL-S in the culture supernatant. Their basal IL-S expression was 1,372±171
pg/ml. Addition of 0.3ng/ml IL-1alpha resulted in significant increase in the IL-S
production (2,274 ±134pg/ml). When we increased the concentration 10-fold to 3ng/ml
the IL-S expression increased to 4,358±13Spg/ml, which was 3.5 times higher than the
unstimulated (basal) value of IL-S. The highest IL-S expression (10,5SS±420pg/ml)
occurred when IL-1alpha was added in the cell culture with concentration 10ng/ml.
Therefore, the level of IL-8 expression was dependent on the concentration of IL-1 alpha
in the range of 0.3 to 10 ng/ml.
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Concentrations higher that 10ng/ml, resulted in decreased viability of GECs. That
was observed microscopically as rounding of the cells and detachment from the bottom
of the tissue culture well. Therefore, the concentration of IL-l alpha that produced the
maximal IL-8 response by GECs was 10 ng/ml for the experimental period of 24 hours.
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Figure 3.8 Dose-response study of IL-8 expression by GEes following IL-lalpha
challenge
GECs were challenged for 24 hours with increasing concentrations of IL-lalpha and the
supernatants were assayed for IL-8. For IL-lalpha values between 1 and 10 ng/ml there
was a linear increase in the IL-8 expression. All the IL-8 values were statistically higher
than the unstimulated controls. (**: p~O.05).
3.2.2. IL-lalpha induces IL-8 expression in a time-dependent way.
The purpose of this section was to determine the kinetics of IL-8 expression by
GECs after exposure to recombinant human IL-l alpha. Cell monolayers were stimulated
with 10 ng/ml IL-1alpha for the following periods: 2h, 4h, 8h, 12h, 24h and 48h.
Expression of IL-8 was determined for each time point by removing the medium from the
specific wells and assaying using ELISA. The results presented in Figure 3.9, are from
one representative experiment out of three.
It is shown that a statistically significant increase in the level of IL-8 protein in
the supernatant was observed as early as 2 hours after stimulation. The IL-8 concentration
at 4 hours was 546±77 pg/ml and was significantly higher compared to the unstimulated
controls. Between the 2 and 12-hour tin1e-point, there was a constant increase in IL-8
concentration, reaching 2,031±261 pg/ml, which was 7-fold higher that the unstimlLlated
controls. The IL-8 expression increased steadily over time and reached the maximum
level (10,736±611 pg/ml) at the 24 hour time-point, which was lO-fold greater that the
non-exposed control. The detectable IL-8 levels decreased to 9,831±1,221 pg/ml, 48
hours after the beginning of the challenge. This probably reflects a decrease in IL-8
expression. However, part of this decrease might be due to degradation of this cytokine,
as well, under the specific experimental conditions (37°C and 100% humidity). A slight
increase in IL-8 expressed in the control (unstimulated) cells was evident during the 48-
hour observation period. This increase may reflect the natural characteristics of IL-8
expression of the PP cell line.
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Figure 3.9 Time-course of IL-8 expression by GECs following IL-lalpha challenge
Stimulation of PP cells with 10 ng/ml rhIL-l alpha induced an increase in the basal IL-8
expression as early as 2 hours post stimulus. The increase was time dependent until the
24-hour time point. The data points represent mean values of triplicate assay
determinations from one representative experiment. (** : p< 0.05)
3.2.3. Comparison of the effect of Interleukin-lalpha and A.a. on the kinetics of
Interleukin-8.
Once we determined the kinetics of the IL-lalpha-induced IL-8 expression we
compared it with the previously reported kinetic study of the A.a.-induced IL-8 in order
to see how GECs respond in different stimuli over time. As shown in Figure 3.10,
stimulation of GECs with 10 ng/ml rhIL-lalpha induced higher IL-8 expression than
stimulation with 50 ug/ml of A.a. sonicates for the same timepoint. The increase for both
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conditions was time dependent until the 24-hour time point. Between 24 and 48 hours,
there were no statistically significant changes in IL-8 expression for both conditions.
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Figure 3.10 Comparison of the effect of IL-lalpha and A.a. sonicates in the
expression of IL-8
Stimulation of GEes with 10 ng/fill rhIL-lalpha induced higher IL-8 expression than
stimulation with 50 ug/ml of A.a. sonicates for the same timepoint. The increase for both
conditions was time dependent until the 24-hour time point. The data points represent
mean values of triplicate assay determinations from one representative experiment. All
values were statistically higher than controls. (** : p< 0.05)
In order to evaluate the relative increase in IL-8 expression, we calculated the fold
increase compared to the unstimulated controls for the corresponding time-points. This is
presented in Figure 3.11, where it can be observed that for the 2 hour time-point both
stimuli cause similar stimulation. However, at the 4-hour time-point, IL-1alpha induced a
4.7-fold increase, whereas A.a. sonicates induced a 2.5-fold increase. At the 8 and 12-
hour time-points, IL-1alpha induced levels of IL-8 three times higher than those induced
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by A.a. sonicates (Figure 3.11). This "early stimulatory effect" of 10ng/ml IL-lalpha
compared to 50ug/ml A.a. sonicates was more intense for the first 12 hours. At the 24 and
48-hour points the fold IL-8 increase induced by A.a. (7-fold and 6.7-fold respectively)
increased and was closer to the IL-8 expression induced by IL-l alpha (10-fold and 8-fold
respectively).
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Figure 3.11 Stimulation Index of IL-8 expression induced by IL-1alpha and A.a.
sonicates
Stimulation of GEes with 10 ng/ml rhIL-lalpha induced higher IL-8 stimulation Index
than stimulation with 50 ug/ml of A.a. sonicates for the same timepoint. The data points
represent the fold increase in IL-8 expression compared to the unstimulated cells for the
corresponding time-points. Notice the "early stimulatory effect" of IL-lalpha compared
to A.a. sonicates. At the 8-hour time-point, IL-lalpha had already induced three times
higher levels of IL-8 than A.a. sonicates had.
3.3. IL-lbeta induces IL-8 expression
In this section it is demonstrated that IL-Ibeta induced significant expression of
IL-8 in GECs. The dose-response and kinetic studies are presented and they are compared
with IL-8 expression induced by A.a.
3.3.1 IL-lbeta induces IL-8 in a dose-dependent way
We have already demonstrated a dose-response relation between the IL-1alpha
challenge and the expression of IL-8 by GECs. Based on the existing literature we know
that IL-1beta is a potent inducer of IL-8 in several cell types. Our purpose was, as with
IL-1alpha, to determine how the concentration of IL-Ibeta would affect the expression of
IL-8 by the PP cell line. Therefore, monolayers of gingival epithelial cells were incubated
for 24 hours in the presence of 0, 0.3, 1, 3, and 10 ng/ml rhIL-lbeta. Then, the
supernatants were collected and assayed for IL-8 using ELISA.
The IL-8 excretion of GEes, stimulated by IL-1beta can be seen in figure 3.12.
The data presented are from one representative experiment out of three consecutive
experiments with similar results. It can be seen that with increasing concentrations of IL-
l beta, cells express more IL-8. The unstimulated IL-8 expression by gingival epithelial
cells was 1,372± 171 pg/ml. Addition of 0.3 ng/ml IL-1beta resulted in significant
increase in the IL-8 expression to 2,095±242 pg/ml. When we increased the concentration
10-fold to 3 ng/ml the IL-8 expression increased to 8,324±1,251 pg/ml, which was 6.6
times higher than the unstimulated (basal) value of IL-8. The maximum IL-8 expression
was 11,011±878 pg/ml when the cells were stimulated with 10 ng/ml IL-1beta. This was
an 8.7-fold increase compared to the basal IL-8 expression. Therefore, the IL-8
expression can be considered dependent on the concentration of IL-1beta, on the range
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0.3 to 10 ng/ml. IL-l beta concentrations higher that 10 ng/ml resulted in reduced viability
of the GECs (rounding and detachment from the bottom of the tissue culture well).
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Figure 3.12 Dose-dependent expression of IL-8 after stimulation with IL-lbeta
GECs were challenged for 24 hours with increasing concentrations of rhIL-l beta and the
supernatants were assayed for IL-8. All the IL-8 values were statistically higher than the
unstimulated controls. (**: p~0.05).
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3.3.2. IL-lbeta induces IL-8 expression in a time-dependent way
In order to determine the kinetics of IL-8 expression in the culture supernatant
after exposure to 10 ng/ml IL-lbeta, time-course studies were performed using gingival
epithelial cell monolayers. Expression of IL-8 was determined for each time point by
removing the medium from the specific wells and assaying using ELISA. The results
presented in Figure 3.13, are from one representative experiment out of four. It is shown
that an increase in the level of IL-8 protein was observed as early as 2 hours after
stimulation. The IL-8 concentration at 2 hours was 427±97 pg/ml and was significantly
higher compared to the unstimulated controls (83±22 pg/ml). Between the 2 and 8-hour
time-point, there was a linear increase in IL-8 concentration, reaching 3566±268 pg/ml,
which was 12 old higher that the unstimulated controls. The IL-8 expression increased
steadily over time and reached the maximum level (11943±979 pg/ml) at 24 hours after
IL-l beta challenge, which was 9-fold greater that the non-exposed control. The
detectable IL-8 decreased 48 hours after the challenge. This probably reflects a decrease
in IL-8 expression. However, part of this decrease might be due to degradation of this
cytokine, as well, under the specific experimental conditions (37°C and humidity).
A slight increase in IL-8 expressed in the control (unstimulated) cells was evident
during the 48-hour observation period. This increase may reflect the natural
characteristics of IL-8 expression of the PP cell line.
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Figure 3.13 Time-course of IL-8 expression following IL-lbeta challenge
Stimulation of GEes with 10 ng/ml rhIL-lB induced an increase in the basal IL-8
expression. The increase was time dependent until the 24-hour time point. The data
points represent mean values of triplicate assay determinations from one representative
experiment. (** : p< 0.05)
3.3.3. Comparison of the effect of Interleukin-lbeta and sonicates ofA. a. on the
kinetics of Interleukin-8 expression
Once we determined the kinetics of the IL-1beta-induced IL-8 expression we
compared it with the previously reported kinetic study of the A.a.-induced IL-8
expression in order to see how the gingival epithelial cells respond in different stimuli
over time. In Figure 3.14 it can be seen that stimulation with 10 ng/ml rhIL-lbeta induced
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higher IL-8 expression than stimulation with 50 ug/ml of A.a. sonicates, until the 24-hour
time point. The increase for both conditions was time dependent. However, at 48 hours,
IL-lbeta-induced IL-8 expression (7620±1472 pg/ml) was significantly lower than the
IL-8 expression induced by A.a.(9927±241 pg/ml).
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Figure 3.14
by A.a.
Stimulation of GEes with 10 ng/ml rhIL-lbeta induced higher IL-8 expression than
stimulation with 50 ug/ml of A.a. sonicates for the first 24 hours.The data points
represent mean values of triplicate assay determinations from one representative
experiment. All values were statistically higher than controls (** : p< 0.05).
In order to evaluate the relative increase in the basal IL-8 expression, we
calculated the fold increase compared to the unstimulated (basal) controls for the
corresponding time-points. This is defined as Stimulation Index and is presented in
Figure 3.15, where it can be observed that at the 4-hour time-point, IL-lbeta induced a 7-
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fold increase, whereas A.a. sonicates induced a 2.6-fold increase. At the 8 and 12-hour
time-points, IL-1 beta induced levels of IL-8 much higher than those induced by A.a.
sonicates This "early stimulatory effect" of 10 ng/ml IL-1beta compared to 50 ug/ml A.a.
sonicates was more intense 8 hours after the beginning of the stimulation with a IS-fold
increase of IL-8 Vs only a 2.6-fold increase for A.a. At the 24 and 48-hour points the
fold IL-8 increase induced by IL-1beta (9-fold and 4-fold respectively) was closer to the
IL-8 expression induced by A.a. (7-fold and 6-fold respectively).
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Figure 3.15 Stimulation Index of IL-8 expression induced by IL-lbeta and A.a.
sonicates
The "early stimulatory effect" that was observed after IL-1 alpha challenge, was more
intense after IL-1beta challenge. At the 8-hour time-point, IL-lbeta had already induced
six times higher IL-8 levels compared to A.a. sonicates. However, after the 24-hour
timepoint, the difference in IL-8 expression was nullified between the two conditions.
3.4. Effect of IL-l inhibitors on IL-8 expression induced by IL-l or by
A.a.
The results of this study will be presented in 4 sections depending on the agent
that we used for the cell stimulation and the inhibitors used. We stimulated the GEes
with either combinations of IL-1alpha and IL-1beta or A.a. sonicates and examined the
effect of IL-1 inhibitors on the IL-8 expression.
3.4.1. Effect of anti-IL-lalpha neutralizing antibodies on the IL-l alpha-induced
IL-8 expression by GEes.
We tested the ability of anti-IL-1alpha neutralizing antibody to inhibit the
inducible and constitutive expression of IL-8 in the PP cell line. Rh IL-1 alpha was added
at a concentration of 5 ng/ml, with or without anti-IL-lalpha or N IgG (Ctrl Ab). The
addition of rh IL-lalpha induced an increase in expression of IL-8 from 281±41 pg/ml to
1972±61 pg/ml. The inducible response was inhibited in a great degree by anti-IL-1alpha,
but not from the same concentration of control antibody. Increasing concentration of anti-
IL-lalpha resulted in increased inhibition (Figure 3.16) and specifically, IL-8 expression
from 1972±61 pg/ml was decreased to 1149±96 pg/ml (49% inhibition) and 793±70
pg/ml (70% inhibition) with the addition of 2 ug/ml and 10 ug/ml anti-IL-lalpha
respectively. This means that anti-IL-1alpha antibody is effective in neutralizing rh IL-
1alpha.
Addition of anti-IL-1alpha had no significant effect on the basal level of IL-8
expression by GECs (Figure 3.16). The level of 5ng/ml rh IL-1alpha that was used as
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stimulant, was 25 times higher compared to the endogenous IL-lalpha levels (200 pg/ml)
that were detected in GEC supernatants, after bacterial stimulation for 24 hours.
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Figure 3.16 Effect of anti-IL-lalpha antibodies on IL-lalpha-induced IL-8
expression
Rh IL-lalpha (5 ng/ml) was added in cultures of GECs, with or without anti-IL-lalpha
antibody or control antibody (Ctrl Ab). Anti-IL-lalpha antibodies significantly reduced
IL-8 induced by rh IL-lalpha. Experimental period was 18 hours. ( ** : p < 0.05).
3.4.2. Effect of anti-IL-lbeta neutralizing antibodies on the IL-lbeta-induced IL-8
expression by GEes.
After demonstrating the effectiveness of anti-IL-l neutralizing antibody on rh IL-
lalpha induced expression of IL-8 we wanted to determine if similar results could be
obtained with anti-IL-lbeta neutralizing antibody, as well. Rh IL-l beta was added at a
concentration of 5 ng/ml, with or without anti-IL-lbeta or N IgG (Ctrl Ab). The addition
of IL-lbeta induced an increase in IL-8 expression (Fig.3.l7) from 28l±4l pg/ml to
2879±183 pg/ml (lO-fold).
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Figure 3.17 Effect of anti-IL-lbeta antibodies on IL-lbeta-induced IL-8 expression
Rh IL-lbeta (5ng/ml) was added in cultures of GECs with or without anti-IL-lbeta
antibody or control antibody (Ctrl Ab). Anti-IL-l beta antibodies significantly reduced IL-
8 induced by IL-lbeta. Experimental period was 18 hours ( ** : p < 0.05 ).
The inducible response was significantly inhibited by anti-IL-1beta, but not from
the same concentration of control antibody. Increasing concentration of anti-IL-1beta
resulted in increased inhibition (Figure 3.17) and specifically, IL-8 expression from
2879±183 pg/ml was decreased to 1591±74 pg/ml (49% inhibition) and 1027±178 pg/ml
(71 % inhibition) with the addition of 10 ug/ml and 50 ug/ml anti-IL-1beta respectively.
Addition of anti-IL-1 beta had no significant effect upon the basal level of IL-8 expression
by GECs (Figure 3.17). It should be noted that the level of 5 ng/ml IL-1beta that was
used as stimulant was 250 times higher compared to the endogenous IL-1beta levels (15-
20 pg/ml) that were detected in GEC supernatants, after bacterial stimulation.
3.4.3. Effect of IL-IRA on the IL-l-induced IL-8 expression by GEes.
After demonstrating the effectiveness of anti-IL-1 neutralizing antibodies on IL-
1alpha/IL-1beta-induced expression of IL-8 we wanted to determine if similar results
could be obtained with IL-1RA, as well.
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Figure 3.18 Effect of IL-IRA on IL-lalpha-induced expression of IL-8
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Figure 3.19 Effect ofIL-IRA on IL-lbeta-induced expression ofIL-8.
Gingival epithelial cells were challenged with 2 ng/ml rhIL-I alpha or rhIL-l beta and 800
ng/ml IL-IRA was added. Experimental period was 18 hours ( ** : p < 0.05 ).
IL-IRA was added at a concentration of 800 ng/ml, with or without IL-lalpha or
IL-l beta. The results showed significant inhibition of IL-8 expression, up to 60%, for
both IL-I alpha and IL-l beta. This validates the effectiveness of IL-IRA in blocking the
receptor for both IL-lalpha and IL-lbeta.
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3.4.4. Stimulation with IL-lalpha and IL-lbeta and addition of IL-l inhibitors
After demonstrating the effectiveness of anti-IL-Ialpha, anti-IL-Ibeta and IL-
IRA on IL-I induced expression of IL-8 we wanted to see how their combination would
affect the IL-8 expression of GEes. Rh IL-Ialpha 5 ng/ml and rh IL-Ibeta 5 ng/ml were
added in the cell culture medium, with or without anti-IL-I antibodies, IL-I RA, or
control antibody (Ctrl Ab). We used concentrations five times higher than NDso for both
anti-IL-Ialpha and anti-IL-lbeta, which was 10 ug/ml and 50 ug/ml, respectively. [The
NDso for anti-IL-Ialpha and anti-IL-Ibeta, was 2 ug/ml and 10 ug/ml respectively, for
neutralization of 50% of the bioactivity of 5 ng/ml IL-l alpha and IL-lbeta].
The addition of IL-1 alpha + IL-1 beta induced an increase in IL-8 expression
(Fig.3.20) from 809±81 pg/ml to 2784±192 pg/ml. The inducible response was not
significantly inhibited by 10 ug/ml anti-IL-1alpha (2672±226 pg/ml) or by 50 ug/ml
control antibody (2745±276 pg/ml) and was slightly inhibited by 50 ug/ml anti-IL-lbeta
(2353±166 pg/ml), as seen in Figure 3.20. This suggests that when either IL-1alpha or IL-
l beta was neutralized, the other cytokine was adequate for stimulating a high IL-8
response. The inducible IL-8 response was also significantly inhibited by 800 ng/ml IL-
IRA (1167±98 pg/ml).
In Figure 3.21 it can be seen that combinations of antibodies with or without
ILIRA can effectively inhibit the [IL-lalpha+IL-lbeta]-induced IL-8 expression.
Specifically the following combinations were tested: a) 10 ug/ml anti-IL-1alpha + 50
ug/ml anti-IL-1beta (1203±192 pg/ml) and b) 10 ug/ml anti-IL-1alpha + 50 ug/ml anti-
IL-1beta + 800 ng/ml IL-1RA (1031±187 pg/ml).
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The basal level of IL-8 expression by GEes was not significantly changed by the
addition of anti-IL-lalpha, anti-IL-lbeta, or II-IRA. (Figures 3.20 and 3.21). However,
addition of IL-IRA or control antibody (N IgG) or combination of those, resulted in a
small, but statistically significant increase in the basal IL-8 expression.
When we calculated the % inhibition of IL-8 expression induced we reached the
following results. The highest inhibition was observed after addition of IL-IRA (82%),
combination of the 2 antibodies anti-IL-lalpha and anti-IL-lbeta (80%) and combination
of the antibodies above with IL-IRA (89%). Also combination of the control antibody
with IL-IRA elicited significant inhibition in IL-8 expression (Fig. 3.21).
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Figure 3.20 Effect of single anti-IL-1 antibodies and IL-1RA on the [lL-1alpha +
IL-1beta] induced IL-8 expression
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Figure 3.21 Effect of combined anti-IL-l antibodies and IL-IRA on the [IL-lalpha
+IL-lbeta]-induced IL-8 expression
GECs were stimulated with IL-1alpha (5ng/ml) + IL-1beta (5ng/ml) with or without IL-1
inhibitors. Anti-IL-1 antibodies and IL-1RA significantly reduced IL-8. Experimental
period was 18hours ( ** :p< 0.05 compared to initial IL-8 expression without antibodies).
• @ IL-I Neutralizing Antibodies
• IL-I Receptor Antagonist (IL-lRA)
Figure 3.22 Effect of antibodies and IL-IRA on IL-l-induced IL-8 expression.
Addition of anti-IL-1 antibodies inhibits the IL-1-induced IL-8 expression in GECs. This
validates the experimental system
3.4.5. Inhibitors of IL-l do not affect IL-8 expression induced by A.a.
We have already shown in section 3.1, that A.a. challenge induced endogenous
IL-lalpha expression by gingival epithelial cells (GECs), as early as 2 hours after the
exposure. We have also shown in sections 3.2 and 3.3 that rh IL-lalpha and rh IL-lbeta,
induce high levels of IL-8 expression, as early as 2 hours post-exposure, in a pattern
similar to the IL-l alpha expression. Our next objective was to study whether IL-8
expression by GECs, after bacterial challenge, is regulated by an IL-l-dependent
autoctine mechanism.
Different combinations of inhibitors were used. The cell supernatants were tested
at 12 and 18 hours for IL-8 expression. Addition of A.a. induced an increase in
expression of IL-8 (first column in every figure) 562±34 pg/ml and 2043±139 pg/ml for
the first 12 and 18 hours respectively. The inhibitors used alone (Fig. 3.23 and 3.25) or in
combination (Fig. 3.24 and 3.26), had no effect on the production of IL-8 in response to
A.a. after 12 and 18 hours of incubation. Therefore, the IL-8 response does not appear to
be regulated by the endogenous IL-l excretion in an autocrine way, for the two time
periods that were tested. We did not test this hypothesis in earlier time points, because the
difference between the unstimulated and stimulated IL-8 levels was small and statistically
significant results were difficult to be obtained.
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Figure 3.23 Effect of single IL-l inhibitors on A.a. -induced IL-8 expression (T=12h)
Gingival epithelial cells were stimulated with A.a. sonicates 20 ug/ml for 12 hours. No
significant inhibition of IL-8 expression was found for any of the IL-1 inhibitors
compared to the initial IL-8 expression induced by A.a.
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Figure 3.24 Effect of combined IL-l inhibitors on A.a.-induced IL-8 expression
(T=12h)
Gingival epithelial cells were stimulated with A.a. sonicates 20 ug/ml for 12 hours. No
significant inhibition of IL-8 expression was detected for any of the combinations of IL-1
inhibitors.
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Figure 3.25 Effect of single IL-l inhibitors on A.a.-induced IL-8 expression (T=18h)
Gingival epithelial cells were stimulated with A.a. sonicates 20 ug/ml for 18 hours. No
significant inhibition of IL-8 expression was detected for any of the IL-l inhibitors.
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Figure 3.26 Effect of combined IL-l inhibitors on A.a.-induced IL-8 expression
(T=18h)
GEes were stimulated with A.a. sonicates 20 ug/ml for 18 hours. No significant
inhibition of IL-8 expression was detected for any of the combinations of IL-l inhibitors.
4. DISCUSSION
GEes express IL-l constitutively.
IL-1 is synthesized by a variety of cells and especially by macrophages activated
by microbial antigens or other cytokines. Therefore most of the studies in periodontal
literature have focused on the monocyte/macrophage reaction to the periodontal
pathogens. There are very limited data on GEe expression of IL-l in response to A.a. We
showed that under resting conditions IL-l alpha is constantly expressed at a rate of
200pg/ml/O.3xl06cells/24h, whereas IL-lbeta is below detectable levels. This finding is
in agreement witl1 Woods et al who reported that the ratio of excreted IL-l alpha to IL-
1beta is more than 10 to 1 in Squamous Cell Carcinoma and HVP-16 cell lines [29].
Johnson et al were able to detect IL-lalpha in culture supernatant of oral keratinocytes
after 24 hours, at a level of 2-3 pg/l04 cells. This amount of IL-lalpha was similar to the
one we reported [7]. The levels of intracellular IL-l alpha that they found were 20 times
higher than the levels of IL-lbeta.
Others have reported lower levels of IL-l alpha compared to our results
(43pg/mlll06cells/24h) [8]. However, they used primary keratinocytes, that usually
express reduced cytokine responses compared to the immortalized cell lines [30].
Primary keratinocytes seem to be able to excrete IL-lbeta. Over a 3-day period,
Yamamoto et al were able to detect significant an10unts of IL-1beta (30 pg/105cells/ml)
produced by primary cultures, derived from healthy gingiva [9]. Future experiments can
examine the IL-l profile of those cells for longer than 48h, which was our experimental
period. Overall, our findings, prove that gingival epithelial cells are similar to skin
epithelial cells in regard to the predominance of IL-l alpha expression Vs IL-lbeta, as
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described by Kupper [5]. This is important given the fact that the role of epidermal
keratinocytes in inflammatory diseases has been extensively studied in the medical
literature [31].
A.a. induces upregulation of IL-l expression in GEes
In this study, we demonstrated that the exposure of gingival epithelial cells (GEe)
to A.a. (A.a.) induces expression of IL-lalpha and IL-1beta (Fig. 3.2 and 3.5). Significant
increases of IL-1alpha and IL-1beta secreted proteins were detected within 2h and 12h,
respectively, compared to the levels in uninfected controls. Bacterial challenge resulted in
rapid increase of IL-1alpha, reaching a 6-fold stimulation compared to the basal levels at
the 12h-timepoint. The IL-1alpha expression later declined to a 2-fold stimulation and
remained there until the end of the experimental period. This "early stimulatory effect"
of IL-1 alpha has never been described before and might be important for the induction of
other cytokine responses, since IL-1alpha is a potent cytokine inducer.
IL-1 beta was also upregulated after exposure to A.a. and reached a level of
30pg/ml after 48h of continuous stimulation. The upregulation of IL-1beta excretion that
we reported in GEes is not observed in human gingival fibroblasts (HGF) stimulated
with A.a. Reddi et al reported that A.a. stimulation failed to stimulate any release of IL-
lbeta [32]. Similar results were presented by Dongari [33]. After exposing HGF to A.a.
they observed no difference in IL-1beta expression.
In our study, the ratio "IL-1alpha:IL-1beta" varied over time. After 24h, the IL-
1alpha levels were approximately 20 times higher than the IL-1 beta levels (ratio 20:1).
After 48h, this ratio became 5: 1 and there was a tendency for further decrease. Therefore,
we can see that IL-1 alpha appears to act as an early mediator after bacterial challenge
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with activity peaking at 12h, whereas IL-lbeta may act as a late mediator with activity
peaking at 48h or even later.
The kinetics of IL-lalpha and IL-8 were then compared. IL-8 peak expression
lagged compared to IL-lalpha peak expression. The IL-8 stimulation index was between
2 and 3 until 12h and then it peaked reaching the value of 7, at 24 h. The delayed
production of IL-8 can be due to the existence of an additional mediator that is induced
by A.a. and stimulates IL-8 expression. In a respiratory epithelial cell line (A549), IL-
lalpha has been identified as an autocrine mediator that is produced by the cells al1d
induces the expression of IL-8 [23]. A possible autocrine mediator has not been identified
in gingival epithelial cells to date. In clinical conditions, expression of IL-lalpha and IL-
beta may take part in the amplification of the immune response, by activating fibroblasts,
macrophages and other keratinocytes to produce IL-lbeta, IL-6, IL-8 and TNF-alpha. The
presence of IL-lalpha and IL-1beta in GCF can also be contributed to GECs in addition
to macrophages and fibroblasts. Our results indicate that GECs are actively involved in
the regulation of the complex cytokine network, in addition to macrophages and other
immune cells.
IL-l induced upregulation of IL-8 expression in GEes
In periodontal diseases IL-1beta has been detected in inflamed gingiva and is
shown to be important mediator of the inflammatory process [10, 12, 14]. The local
generation of IL-1beta by macrophages in the gingiva after bacterial infection can act in a
classical paracrine function to induce the expression of IL-8 by non-immune cells. In our
study we examined how rhIL-1 affects the basal IL-8 expression by gingival epithelial
cells. A dose-response relation was shown with maximum stimulation of IL-8 by 10
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ng/ml IL-lalpha and IL-lbeta. The IL-8 levels were comparable with the A.a.-induced
levels and ranged between 10,000 and 12,000 pg/ml for a 24h stimulation period.
Concentrations as low as 0.3 ng of IL-lalpha or IL-lbeta were capable of inducing
significant IL-8 response above the basal levels. These results are in agreement with other
authors that have demonstrated that IL-l upregulates the IL-8 produced by oral epithelial
cells in a dose-dependent manner [20].
The kinetic study on IL-8 production revealed that significant IL-l expression
occurred as early as 2 hours after the beginning of stimulus. At the 8 hour timepoint the
IL-8 expression due to IL-lalpha was 7-fold compared to the basal levels and the IL-8
due to IL-lbeta was 15-fold the basal levels. Therefore, we have shown that IL-lbeta is
more potent stimulator, especially for the early timepoints, inducing twice as much IL-8
than IL-lalpha. Another possible explanation for this phenomenon is that the epithelial
cells are genetically predisposed to be more reactive to IL-lbeta challenge, reflecting the
critical role that this cytokine plays in the inflammatory microenvironment. Bickel et al
studied the influence of IL-l alpha on chemokine expression of 2 human oral
keratinocyte cell lines. IL-l stimulation resulted in an increase of mRNAs encoding IL-8
IL-8 mRNA was expressed as early as 1 hour after stimulation [21]. We also
demonstrated that the stimulatory potential of IL-lbeta was reduced, after the 24h
timepoint, to levels lower than those induced by A.a. This "early stimulatory effect" of
IL-l compared to the bacterial extracts suggests a direct effect of IL-l on epithelial cells
versus a possible indirect effect of A.a. IL-8 derived from gingival cells, including
gingival epithelial cells can cause neutrophils to accumulate and to be activated in the site
of inflammation. Thus, the capacity of the gingival epithelial cells to produce IL-8 in
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response to IL-lalpha, IL-lbeta or A.a. suggests that they playa critical role in the
maintenance of the tissue microenviroment.
Effect of IL-l inhibitors on IL-l-induced expression of IL-8
In this chapter (Chapter 3) we hypothesize that IL-l is involved in the A.a.-
induced expression of IL-8 in an autocrine manner and we use IL-l inhibitors (rhIL-lRA
and anti-IL-l neutralizing antibodies) to block the extracellular IL-l and its receptors.
However, it is important to validate our antibodies and antagonist first. Therefore, we test
whether they can inhibit IL-l-induced 11-8 expression in GECs
The level of 5 ng/ml IL-l that was used as stimulant, was 25 times higher
compared to the endogenous (GEe excreted) IL-lalpha levels (200 pg/ml) and
approximately 160 times higher compared to the endogenous IL-lbeta levels (30 pg/ml)
after bacterial stimulation for 24 hours. Therefore, neutralization of those high
concentrations of exogenous IL-l would definitely indicate that the inhibitors are
adequate for neutralizing the smaller amounts of endogenous IL-l.
We found that addition of IL-l inhibitors reduced by 70% the IL-l-induced IL-8
expression. This confirmed that the anti-IL-l neutralizing antibodies and IL-IRA were
active and that they were added in excess. In our experiments we used 2 concentrations of
antibodies. The first was equal to the neutralizing dose 50 (NDso) determined from the
manufacturer (R&D Systems) and the second was 5 times higher. NDso is defined as the
concentration of antibody that inhibits 50% of the bioactivity of rhIL-l that is added to a
mouse T-cell system and is calculated based on the amount of rhIL-l that is being used
(R&D Systems). Thus we were able to validate the data provided by R&D Systems, since
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addition of concentration equal to NDso from each antibody, inhibited practically 50% of
the IL-l-induced expression of IL-8 in the GEC system.
When we increased the antibody concentration x5, the resulted inhibition of IL-8
increased from 49% to 70% for anti-IL-lalpha and from 49% to 71 % for anti-IL-lbeta
proving the effectiveness of those 2 antibodies. This revealed a dose-dependent effect of
anti-IL-l antibodies.
We also asked whether the combined addition of rhlL-lalpha and rhlL-lbeta
would have a cumulative effect of IL-8 expression. This simulates closer in vivo
conditions since GECs secrete both IL-lalpha and IL-lbeta when stimulated with A.a.
Therefore, we added a mixture of 5ng/ml IL-lalpha and 5ng/mIIL-lbeta to the GEC
culture and we examined the effect of anti-IL-lalpha, anti-IL-lbeta and IL-IRA when
added separate, or in combinations.
IL-IRA was as effective as the combination of anti-IL-lalpha and anti-IL-lbeta
together in the neutralization of the 2 forms of IL-l. This is direct evidence that IL-l
receptor in gingival epithelial cells is non-specific and binds both IL-lalpha and IL-lbeta.
It is currently known that there are two kinds of IL-l receptors [34]. Type-l receptor is
expressed predominantly on T-cells and cells of mesenchymal origin. Type-2 receptor is
expressed predominantly on B-cells and cells of the myelomonocytic lineage. Type-l and
Type-2 receptors bind both types of IL-l. We conclude that the use of IL-IRA in
experiments provides an effective way to neutralize both forms of IL-l. However, if
specific neutralization of IL-l alpha or IL-lbeta is required, then antibodies should be
used instead.
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Effect of IL-l inhibitors on A.a.-induced IL-8 expression
Once we demonstrated the effectiveness of our inhibitors, we used them to
neutralize the GEe-excreted IL-l alpha and IL-lbeta after bacterial challenge. Inhibitors
of IL-l did not prevent activation of GECs by A.a., as measured by production of IL-8
excreted in the culture medium. This was the case for stimulation periods of 12 and 18
hours.
Although we cannot rule out possible involvement of intracellular IL-lalpha [35]
our results show that stimulation of epithelium by A.a. occurs independently of secreted
IL-l. This finding was unexpected, given that GECs are capable of producing IL-lalpha
and IL-lbeta and respond to these cytokines in the same way as they do to A.a regarding
the IL-8 expression. Given the fact that IL-lalpha is the first mediator that reaches peak
activation soon after bacterial challenge, it seemed likely that excretion of IL-lalpha
would mediate stimulation of GEes by A.a.
To our knowledge, the participation of IL-l in the IL-8 expression has never been
tested in GECs. In other cells types such autocrine regulation has been demonstrated.
Specifically, in cultured endothelial and pulmonary epithelial cells IL-lalpha has been
shown to be an autocrine regulator of IL-8 production [22, 23]. Porat et al showed that in
PBMCs endogenous IL-l induced IL-8 after bacterial stimulation [24].
How A.a. effects IL-8 stimulation of GECs is an open question. Here are some
possible answers:
• Perhaps A.a. elicits production of an unidentified host cytokine with functions that
overlap those of IL-l. TNF-alpha seems to be a candidate for this function, but no
data have ever been published about that.
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• Alternatively, direct binding of A.a antigens to endothelial cells may initiate signaling
mechanisms that are used both by IL-8 and by IL-1. That means that IL-8 expression
is completely independent to endogenous IL-1. A proposed way to test this
hypothesis is to knock-out the gene for IL-1 in GECs and to evaluate the IL-8
production after A.a. stimulation. If IL-8 remains unchanged after that, it means that
the above hypothesis is correct and IL-8 and IL-1 are not functionally related. If IL-8
expression is affected (reduced), that leads to the third possibility.
• The third possibility is that IL-8 expression is regulated by an IL-1-dependend
intracrine mechanism. Previous studies by others have shown that IL-1 translation
product undergoes a unique pattern of processing, giving rise to two proteins. One 17-
kDa C-terminal segment, referred to as "mature" or processed IL-1alpha and one 16-
kDa N-terminal propiece. The C-terminal segment is secreted and binds with the IL-1
receptors. The N-terminal piece is actively transported to the nucleus [36]. Here, we
hypothesize that the N-terminal part of IL-1alpha, that is produced in response to the
bacterial challenge, returns to the nucleus and induces the expression of IL-8. As we
mentioned above one way to validate this option is to knock-out the IL-1alpha gene
and to see if IL-8 is affected after bacterial challenge.
These above hypotheses are presented diagrammatically in Figure 3.26. It can be
seen that bacterial stimulation induces IL-1 and IL-8 excretion. The Autocrine hypothesis
is indicated with the bigger question mark ( ? ) and interrupted arrow. The Intractine
hypothesis is indicated with the smaller question mark ( ? ) and continuous arrow. Based
on our results the autocrine hypothesis should be ruled out since IL-1 inhibitors did not
reduce IL-8 expression after A.a. challenge. Further experiments should be performed in
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order to show which one of the remaining 2 hypotheses is true. This will contribute to a
better understanding of the transcriptional activation and autocrine loops involved in
expression of proinflammatory cytokines and their role in periodontal disease.
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Figure 3.27 Possible mechanisms oflL-8 regulation by bacterial induced-IL-l
-Intracrine pathway of IL-8 control involves the direct action of IL-I within a cell. The
IL-Ialpha N-terminal segment is transported to the nucleus soon after IL-Ialpha is
synthesized and induces IL-8 expression (small question mark, small solid arrows).
-Autocrine pathway of IL-8 control involves secretion of IL-1 that binds to its receptor,
which is expressed also by the cell. This creates an autocrine loop in which IL-1 acts
back on the cell and induces IL-8. (large question mark, interrupted arrow).
-Parallel pathways indicate that secretion of IL-8 and IL-1 is independent from each
other (large solid arrows).
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IL-l N-terminal segment is transported to the nucleus soon after IL-l is synthesized and
induces IL-8 expression (small question mark, small solid arrows).
-Autocrine pathway of IL-8 control involves secretion of IL-l that binds to its receptor,
which is expressed also by the cell. This creates an autocrine loop in which IL-l acts
back on the cell and induces IL-8. (large question mark, interrupted arrow).
-Parallel pathways indicate that secretion of IL-8 and IL-l is independent from each
other (large solid arrows).
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CHAPTER 4
CONCLUSIONS
Based on our findings we reached the following conclusions:
1. Both IL-8 and IL-8 receptors are present in gingival epithelial cells (GECs) in vivo and
in vitro
2. A.a extract (A.a.E.) can induce dose- and time-dependent IL-8 expression in GECs in
vitro
3. In GECs, A.a.E.-induced expression of IL-8 is not the direct result of major IL-8
induction pathways (i.e. LPS or IL-l).
4. GECs are the only cells studied so far that do not respond to LPS by upregulating IL-8
expression
5. In GECs, A.a.E.-induced expression of IL-8 involves a p38 MAPK signal transducing
pathway unlike the IL-lbeta-induced IL-8 expression
6. GEC are likely a major source of IL-8 in vivo and in vitro
7. A.a.E.-induced expression of IL-8 in GECs likely contributes to the pathogenesis of
periodontal disease
SIGNIFICANCE
A.a.E.-induced expression of cytokines from GECs likely controls inflammation and
repair in periodontal disease. Thus, GECs can be a potential target for therapeutic
intervention in the future for the treatment of periodontal disease.
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FUTURE DIRECTIONS
Directions for future research relevant to this project include:
• Identify the mechanisms of A.a.-induced IL-8 expression. This is an unexplored
field since we don't really know how A.a. induces IL-8 in GECs. We have taken the
first step by reporting the role of p38 MAP kinase in the signal transduction pathway.
• Identify A.a. factors that induce IL-8 expression in GEes. We have shown that
A.a.-induced IL-8 expression is not LPS or IL-l dependent in GECs. Thus, the
mediating factors are yet to be discovered.
• Suppress in vitro and in vivo IL-8 expression by using antibodies against A.a.
virulence factors. Once the virulence factor(s) of A.a. are discovered, they can be
targeted with specific antibodies.
• Explore the use of p38 MAPK inhibitors to supress IL-8 expression and
inflammation in vivo. Future clinical trials can utilize cytokine inhibitors to
selectively down-regulate the host response to the bacterial antigens without altering
basal cytokine expression.
• Characterize other cytokines induced in GECs by A.a. We are currently
investigating the expression of IL-6 in GECs. However, there is a variety of cytokines
to be studied, especially proinflarnmatory ones, such as TNF-alpha.
• Determine the role of IL-l family members in the expression of other cytokines
in GECs. Even though IL-l does not mediate IL-8 expression in GEes, it may
mediate expression of other proinflammatory cytokines. This is yet to be investigated.
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